• 沒有找到結果。

利用非侵入式取樣方法分析BoLA-DRB3.2基因與乳房炎及泌乳性狀之關係

N/A
N/A
Protected

Academic year: 2022

Share "利用非侵入式取樣方法分析BoLA-DRB3.2基因與乳房炎及泌乳性狀之關係"

Copied!
77
0
0

加載中.... (立即查看全文)

全文

(1)

୯ҥᆵ᡼

ҔߚߟΕ

nalysis o astitis, a

᡼εᏢғ

D Colle

N

ΕԄڗኬ

of relati nd milk

ࡰ Adv

ғނၗྍ

Departmen ge of Bior

National T Ma

ኬБݤϩ ݹϷݜ onships k traits b

Jyun

ࡰᏤ௲௤

visor: Pe ύ๮҇

Ju

ྍᄤၭᏢ ᅺγፕЎ

nt of Anim resources

Taiwan U aster The

ϩ݋ Bo ݜ٢܄ރ

s betwee by nonin

݅ߪֻ

n-Hong

௤ǺЦٵ ei-Hwa W

҇୯ 100 uly, 201

Ꮲଣ୏ނ Ў

mal Scienc and Agric

Universit esis

oLA-DR ރϐᜢ߯

en BoLA nvasive

ֻ g Lin

ٵ๮ റγ Wang, P

ԃ 7 Д 11

ނࣽᏢמ

ce culture

ty

RB3.2 ୷

߯

A-DRB3 samplin

γ Ph.D.

מೌᏢس

୷Ӣᆶ٢

3.2 allel ng metho

س

٢܊

les, ods

(2)

ૈֹԋ೭ҽ ࢲ΢ᆶፐ཰΢

ᓉە! റγޑ Ўளа׳уֹ

གᖴسᒤϦ

໺܍ᆶϩ٦

ࢂᒧ᏷ࣴز ӧ҂ٰں᝘๏

གᖴჴᡍ࠻

գॺӧჴᡍ ሶӭޑྃДࢂ

Ѻ਻Ƕགᖴ གᖴϩғࣴ

നࡕǴགᖴ

ीၗ਑Бय़ϐ

ୖуКᖻޑუ

ҽፕЎǴ၈

΢ϐᜢЈǴ ޑεΚڐշ

ֹ᏾Ƕ Ϧ࠻ࠧ໥Ꮲ ǶऩࢂؒԖ ز܌Ƕίق

๏ޗ཮Ƕ

࠻ޑ܃ඁǴ ᡍ΢ᆶғࢲ

ࢂךޑᄪ۩

ᖴၭ൑ޑᎄ

ࣴᆶౢࠔу ᖴৎΓॺܭ ϐڐշϩ݋

უՔ୯҉ǵ

၈ኑགᖴࡰᏤ ҭ٬Ꮲғ७ շǴٿՏԴৣ

ᏢۆᆶՏػᏢ Ԗࠧ໥Ꮲۆޑ ق࿤ᇟΨ߄ၲ

ྷଈǴ܃⣬

ࢲ΢ޑڐշ٬

۩ǶќѦ੝ձ ᎄՏܴӃғᆶ уπ࠻ܭሺᏔ ܭᅺγ੤ය໔

݋Ƕགᖴ㧦Ϭ εݞǵ੏ӹ

ठᖴ

Ꮴ௲௤Цٵ ७གྕཪǶ

ৣܭα၂ය

ᏢߏޑऐЈ ޑڐշǴΨ

ၲόΑ೭ҽ

⣬ǴޱျᏢ

٬ჴᡍ࠻ԋ ձགᖴဃᝬ ᆶख़࠶Ꮲߏ ᏔБय़ޑЍ ໔ӧғࢲ΢

Ϭ೭٤Вη ӹаϷٵী

ٵ๮ റγޑ ќѦགᖴα ය໔ޑࡰ҅ᆶ

ЈᆶගឫǴа Ψ೚ך཮፯΢

ҽགᖴǴᜫԾ

ᏢߏǴٵሺ ԋࣁ΋ঁऍӳ ᝬޑڐշǴࡐ ߏǴаϷၭ൑

Ѝජᆶڐշ

΢ޑڐշᆶх ηٰޑЍ࡭ᆶ

ীǴᡣჴᡍϐ

ޑ஼Ј௲Ꮴᆶ α၂ہ঩΍

ᆶፕЎঅׯ

аϷ݅ৱҸ

΢ֹӄόӕ ԾρΨૈа

Ǵ܃ᑉǴҲ ӳޑӦБǴ ࡐଯᑫךॺ

൑ޑמπܭ Ƕ

х৒ǴΨ੝

ᆶഉՔǴΨ ϐᎩϝԖॣ

ᆶࡰ҅ǶԴ

΍၃ӕ! റγ ׯޑගᗺࣣ٬

Ҹ! റγ๏ϒ ӕޑΓғၰၡ аӕኬคدޑ

ҲಡǴߘ⣶

ૈᆶգॺو ॺૈӧനࡕᜢ ܭኬҁ௦໣ϐ

੝ձགᖴް׌

Ψགᖴ೭൳ԃ

ॣ኷ޑኃᙖ Դৣܭ

γᆶ

٬ҁ

ϒ࿶

ၡǴ ޑЈ

Ǵྷ

وၸ ᜢᓐ ϐڐ

׌ܭ ԃ΋

Ƕ

(3)

ᒵ………

ԛ………

ԛ………

Ўᄔा………

Ўᄔा………

߻ق………

Ў᝘ᔠ૸…

΋ǵ٢ҔФ Βǵ٢܊ݹ Οǵғ٢ኬ ѤǵФଫЬ

׷਑ᆶБݤ

่݀ᆶ૸ፕ

่ፕ………

ୖԵЎ᝘…

………

………

………

………

………

………

………

Фϐᅿᜪ…

ݹϐϟಏ…

ኬࠔճҔϐ Ьाಔᙃ࣬

ݤ…………

ፕ…………

………

………

………

………

………

………

………

………

………

………

………

ϐϟಏ………

࣬৒ፄӝᡏ୷

………

………

………

………

Ҟᒵ

………

………

………

………

………

………

………

………

………

………

୷Ӣϐࣴز

………

………

………

………

………

………

………

………

………

………

………

………

………

………

ز………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

।ԛ

…… 1

…… 2

…… 3

…… 4

…… 6

…… 8

… 10

… 10

… 15

… 25

… 31

… 37

… 45

… 69

… 70

(4)

1. தـϐ٢ 2. а໺಍ݤ 3. λႵᆶΓ 4. ၂ᡍ೛ी

5. Ծғ٢ኬ 6. PCR ౢ 7. ᡏಒझኧ

. ٿᅿόӕ

٢ҔФଫࠔ ݤܜڗФ٢ Γᜪ MHC

ीࢬำკ…

ኬҁܜڗ୷ ނપϯϐࢬ ኧȐSCCȑ

୘Ҕ঺ಔ D

ࠔᅿ………

DNA ϐࢬ

୷Ӣ………

………

Ӣಔ DNA ࢬำკ……

ȑᆶ٢ಔԋ DNAϐႝݚ

კԛ

………

ࢬำკ……

………

………

A ࢬำკ…

………

ԋϩϐᜢ߯

ݚ่݀Кၨ

………

………

………

………

………

………

߯…………

ၨ…………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

………

।ԛ

… 14

… 29

… 32

… 38

… 42

… 43

… 51

… 57

(5)

1. ऍ୯՗ी

2. Ф٢ᡏಒ 3. ճҔϤᅿ 4. ܰ௵ག܄

5. ٢܊ݹᆶ 6. ҂วݹය . ٢ໆᆶ٢ 8. ٢ໆ଑ᘜ 9. ٿᅿόӕ 10. Ѡεၭ

1. Ѡεၭ൑

2. ל٢܊ݹ 3. ΋૓܄ဂ 4. ܰ௵ག܄

5. όӕҬඹ

ी؂ԃ؂ᓐ ಒझኧ֖ໆ ᅿόӕБݤ

܄ǵ΋૓܄

ᆶғ٢ࠔ፦

ය໔ᆶวݹ ٢ಔԋϩϐ P

ᘜኳࠠ……

ӕ୘Ҕ঺ಔ

൑ݜ٢Фϐ

൑ϐ಻ើФ ݹဂಔϐҬ ဂಔϐҬඹ

܄ဂಔϐҬ ඹ୷Ӣࠠᆶ

Ӣ٢܊ݹϐ ᆶ٢ౢໆཞ ԾᆟԲ٢ύ

܄аϷל٢ ϐᜢ߯……

ය໔ϐ٢ໆ Pearson࣬ᜢ

………

ಔܜڗ DNA ϐ DRB3.2 Ф DRB3.2 ୷ Ҭඹ୷Ӣࠠᓎ ඹ୷Ӣࠠᓎ౗

Ҭඹ୷Ӣࠠᓎ ᆶ٢ಔԋϩϐ

߄ԛ

ϐཞѨ……

ཞѨԭϩК ύܜڗ DNA

܊ݹဂಔϐ

………

ໆᆶ٢ಔԋ ᜢંତ……

………

A ϐКၨ…

Ҭඹ୷Ӣ

୷Ӣࠠᓎ౗

ᓎ౗………

౗…………

ᓎ౗………

ϐᜢ߯……

………

ᜢ߯………

A ϐКၨ…

ϐ٢ໆᆶ٢

………

ϩКၨ……

………

………

………

ࠠᓎ౗……

ᆶВҁϷу

………

………

………

………

………

………

………

٢ಔԋϩКၨ

………

………

………

………

………

………

у৾εϐК

………

………

………

………

………

………

………

ၨ…………

………

………

………

………

………

………

Кၨ…………

………

………

………

………

।ԛ

… 19

… 22

… 30

… 46

… 47

… 48

… 54

… 55

… 57

… 60

…. 61

… 63

… 64

… 64

… 68

(6)

٢ౢໆᆶғ ӭъ۹ౣӵ Ъख़ाϐ੯ੰ

ϐᛌᙴৣ຤

ޣёૈ೷ԋ٢

኱૶ᑔᒧǴଞ Ѩ฻ፐᚒǶ

Ьाಔᙃ࣬

৲৲࣬ᜢǶФ gen, BoLA

੯ੰխࣝᆶ RB3ȑς೏

ёૈᆶФଫխ ϐғ٢ኬҁڗ Չ ࣴ ز ϐ ё

rovementȑ ϐᜢ߯຾Չ ΟঁဂಔǴϩ ݹဂಔȐ40%

ҁ၂ᡍ่݀

A٠຾Չ P ག܄ဂಔԖ 4

2703Ҭඹ୷

՟ϐ่݀

ғ٢ಔԋϩ ӵלੰ܄฻

ੰǴ΋ѿФ

຤Ҕǵᛰނ ٢ФගԐి

ଞჹԜᜪ୷

࣬৒ፄӝᡏ ФଫЬाಔ

ȑǴҗΟঁό ᆶғౢ܄ރ

೏ว౜ڀԖ࣬

խࣝ܄ރ࣬

ڗж໺಍ϐ ё ૈ ܄ Ƕ ၂

ၗ਑аଞჹ Չ૸ፕǶФ ϩձࣁܰ௵

%аΠȑǶ

݀ᡉҢܭ 2 CR-SBTϩ 4ᓐǶܭԜ 1

୷Ӣࠠ໻ـܭ ǴᡉҢځࣁ

ϩϐගϲதࣁ

฻ख़ाϐ٢Ф Фଫགࢉ٢܊

ނǴаϷቲక

ి؎Ƕ߈ԃϐ

୷Ӣ຾΋؁ޑ

ᡏȐmajor hi ᙃ࣬৒ፄӝ όӕ୔ୱಔ ރϐ᝼ᚒύቶ

࣬྽ଯࡋϐ

࣬ᜢǶҁ၂ᡍ ϐՈనᆶಔᙃ ၂ ᡍ ය ໔ ӕ

ჹᡏಒझኧ Фဂ٩ځܭ၂

௵ག܄ဂಔ

3 ᓐ၂ᡍФ ϩ݋ǹځύל

7ᓐঁᡏύ ܭל٢܊ݹ

΋ؼӳϐל

ᄔा!

ࣁݜ٢Фϐ Ф଼ந܄ރ

܊ݹǴό໻

కϐғ٢฻

ϐࣴزว౜

ޑࣴز܈ё

stocompatib ӝᡏ೏ᆀࣁ ಔԋЪᆶלচ

ቶݱӦ೏ࣴ

ϐӭᄊ܄ǴЀ ᡍԏ໣ٰԾ

ᙃኬҁǴа ӕ ਔ ԏ ໣ ٢ ኧȐsomatic c ၂ᡍය໔ᡏ Ȑ100%ȑǵ

ФଫύǴԖ ל٢܊ݹဂ ύӅว౜ 11

ݹᆶ΋૓܄

ל٢܊ݹҬ

ϐЬाػᅿ ރǶ!ᖐٯԶ

໻ᏤठΓΚ

฻ӢનᏤठ

౜ࢌ٤੯ੰ

ёှ،Ӣ੯

bility comp ФଫరЃౚ চև᝘Ԗᜢ

ࣴزǶBoLA ЀаಃΒঁ

Ѡ᡼εᏢ၂ а௖૸ճҔ ٢ Ф ဂ ܄ ૈ

cell countsȑ ᡏಒझኧၲ

΋૓܄ဂಔ

17 ᓐঁᡏ ဂಔԖ 6 ᓐ

ঁόӕϐ D ဂಔύǴᆶ

ඹ୷ӢࠠǶ

Ҟ኱ǴฅԶ ԶقǴ٢܊ݹ

ԋҁቚу ቚуᚐѦϐ ϐל܄܈ё

ੰԶ೷ԋϐ

lexȑᆶথ٢ ౚלচȐbov ᜢǹӢԜǴB

୷Ӣ০΢ಃ

ঁѦᡉηȐe ၂ᡍၭ൑ 23

ߚߟΕԄ௦

ૈ ׯ ຾ ी ฝ ȑᆶғ٢ಔ

ᖏ׉٢܊ݹ ಔȐ40 Կ 80

ᡏёԋфԾ٢ Ǵ΋૓܄ဂ DRB3.2Ҭඹ ᆶу৾εܿ۞

Ƕ*1501 Ҭඹ

Զߏයᒧܘ ݹࣁݜ٢Ф ǴЪӢܭݯ ϐғౢԋҁ ёᙖҗխࣝ

ϐ٢ໆᆶಔ

٢୏ނϐխ vine lymph BoLA୷Ӣ

ಃΟঁ DR exon 2ȑϐ

3ᓐ಻ើФ ௦ኬܭݜ٢ ฝ Ȑ Dairy ಔԋϩᆶ DR

ݹ฻ભϐᓎ 0%ȑǴаϷ

٢ࠔኬҁύ ဂಔԖ 7 ᓐ ඹ୷ӢࠠǴ*

۞ϐ಻ើФ ඹ୷Ӣࠠϐ

ܘޑၸ Фനத ݯᕍၸ ҁǴ׳

ࣝᆶᒪ ಔԋϩ

խࣝس hocyte Ӣςܭ

୔ୱ ϐӭᄊ Фݜ٢ ٢Фଫ Herd RB3.2 ᓎ౗ϩ Ϸל٢

ύܜڗ ᓐǴܰ

*1201 Фࣴز ϐપӝ

(7)

໻ـܭܰ௵ག Ң၀Ҭඹ୷Ӣ

ᗖӷǺФଫర

ག܄ဂಔύ Ӣࠠᆶ٢܊

రЃౚלচ

ύǴЪ஥ԖԜ ݹϐ௵ག܄

চǴDRB3.2

!

Ԝપӝηϐ

܄࣬ᜢǴࡌ

Ǵ٢܊ݹǴ

ϐঁᡏځว ࡌ᝼Вࡕёӈ

Ǵ٢ФǶ

ݹำࡋ֡ଯ ӈࣁػᅿᒧ

ଯܭځдФ ᒧܘϐୖԵ

ФଫǴ Ƕ

(8)

Increasing n breeding

tance have d-wide dis nditures of arding milk

be genetica nomical los

umers. Con ied expectin

The major mmalian im phocyte anti antigens pre

es as well morphic, an y, we collec actions from preliminary a from Dair stigate the r B3.2 alleles.

led the cow mal (40 to 80

productivit goal for d been ignore ease in da f labors, vet k, and cullin

ally determ ses and in nsequently, ng to be use r histocom mmune syst igen (BoLA

sentation. H as produc nd exon 2 (

cted milk s m 23 dairy H

feasibility o ry Herd Imp relationship . According ws into thr

0%), and se

ty such as dairy cattle

ed for a lon iry herds a t service, dr ng of cows mined. Selec crease milk

genetic a d in disease mpatibility c tem. For d A) complex,

Hence, BoL ction traits.

(DRB3.2) m samples ins Holstein cow

of construct provement p between s

g to the fre ree classific ensitive one

Abstract

milk yields e. However ng time. For

and leads t rugs, but al s. Nowaday cting resista k quality, w and immun e resistance complex (M dairy cattle , consisting LA genes ha . The DRB may potenti stead of blo ws in NTU ting noninv

(DHI) in re somatic cell equency of cations, kno

(100%).

t

s and milk r, some hea r example, m to not only lso the loss ys, it is evid

nce to heal which is im nological m

selections.

MHC) grou e, MHC r

of three cl ave been ex B3 locus o

ially affect ood or tissu Experimen asive sampl ecently five l counts (SC

that SCC r own as res

componen alth traits mastitis is a y add cost ses from low

dent that di th problem mportant to markers hav

ups are cl referred to

asses and b amined for of BoLA c immunity ue as the re ntal Farm, tr ling method e months w

CC), milk c eached clin sistant grou

nts is alway such as di an importan ts, includin

wer produc isease resis ms can reduc o ranchman ve been w

losely linke as the b being respon

various im class II is

in cattle. In esource of rying to eva ds in dairy h were also us

components nical mastit up (under 4

ys the isease nt and g the ction ,

stance ce the n and widely

ed to ovine nsible mune very n this

DNA aluate herds.

sed to s, and is we 40%),

(9)

The result essfully in ormal, and e found. All not in sensi allele *15 itive group, e of mastitis

words: BoL

ts showed PCR-SBT a four in sen leles *1201 itive one, an 501 homozy , which ma s in breedin

LA, DRB3.2

17 individ analysis, inc nsitive, resp

and *2703 nd this resu ygous expr ay tend tow ng.

2, mastitis, c

duals from cluding six pectively. A 3 were only

ult is in acc ressed mor ward inflamm

cows.

23 dairy individuals Among thes y found in r cordance wi re serious m

mation easi

cows could s in resistan e 17 indivi esistance an ith former s mastitis lev er. It may b

d be seque nce group, iduals, 11 a

nd normal g study. Indiv vel and on be the cand

enced seven alleles group vidual nly in

didate

(10)

Ѡ᡼٢཰ϐ 2ԃ 1 Д 1

ϣႀၭ٣཰

ᆶऍ୯εໆ٬

೷ԋᕇճޜ໔ ஏᅱ௓ғ٢ࠔ Οε੯ੰȐഋ ԋҁǶ٢܊ݹ చҹϐ΋ǴӢ ݹϐวғջࣁ ߈ԃٰᒿ๱

FᢀۺǴջ m discomfort ܭ৮ឨϷᓸΚ

eedom to ex 1ДϦѲΑ ౦ǴаϷᆅ౛

ࢂჹΓᜪᙴᏢ ᡍϐௗڙࡋஒ х֖ჹӚ၂ᡍ

٬Ҕ୏ނ຾

ኧҞࣁϐ धϐԵໆΠ

ϐว৖ςҗ В҅ԄуΕ

཰य़ᖏ׳ࣁ

٬Ҕҏԯғ ໔ϐཞѨǶ ࠔ፦Ǵۈૈ

ഋǴ2002ȑ ݹϐวғҭ ӢԜӧటӕ ࣁ࣬྽ख़ा

๱୏ނᅽճ խܭទ෰Ȑ tȑǵխܭ໾

ΚȐfreedom xpress norm

ჴᡍ୏ނࡰ

౛ნϣҺՖ ᏢཱུԖଅ᝘

ஒவ 83 फ़Կ ᡍ୏ނᆶᚲ

຾ՉࣽᏢᔈ Ǵ٠а٬୏

Π܌ुۓϐ

җԐයλೕ

ΕШࣚຩܰ

ࣁᚳεϐѱ൑

ғౢඹжૈྍ

ӧ୯ϣ٢ౢ

ૈᆢ࡭΋ۓϐ Ǵନ٢ໆϐ ҭ཮Ꮴठғ٢ ӕਔ௓ᆅғౢ

ाϐፐᚒǶ ճᆶΓၰཀ᛽

Ȑfreedom fr

໾্ǵภधᆶ m from fea mal behavio

ࡰзঅ҅ࡰ

Ֆ୏ނჴᡍϐ

᝘ϐ၂ᡍǴ΋

Կ 65%ǶѠ ᚲނ຾Չᏹբ

ᔈҔǴᔈᏃໆ

୏ނౢғനϿ ϐǶ

൘ǵ߻ق

ೕኳϐ࿶ᔼ ಔᙃȐWor

൑ᝡݾǶ20

ྍϐ௃ݩΠ

ౢໆදၹό ϐᝡݾΚǶ ϐཞѨϐѦ

٢ύᡏಒझ

ౢԋҁᆶғ

᛽ܩᓐǴԐ from hunger ᆶ੯ੰȐfr ar and distre orȑǶࣁၲԋ

ࡰзගਢǴ׆

ϐ຾Չǹऍ

΋ѿ၂ᡍ୏

Ѡ᡼ܭ 2010 բႩᎦೕጄ ໆᗉխ٬Ҕ ϿภधϷ໾

ق!

ኳԄᙯࣁҾ rld Trade Or 006 ԃǴӧ ΠǴठ٬ႀ όىϐ௃ݩ Ƕ٢܊ݹǵ Ǵۘ೷ԋ೚

झኧቚуǴ ғ٢ࠔ፦ϐ

Ԑܭ 1960 ԃ r and thirstȑ

eedom from essȑǴаϷ ԋமϯ୏ނᅽ

׆ఈૈ୼ᕭ ऍ୯୏ނߥ

୏ނᎁڙੵ

0ԃ 1 Д 27 ጄᆶݤచѦ

Ҕࢲᡏ୏ނ

໾্ϐБԄࣁ

Ҿ཰ϯࠠᄊ rganization, ӧӕਔڙډ୯

ၭႩ਑ԋҁ ΠǴ୤Ԗफ़ ᕷ෗ምᛖϷ

೚ӭݯᕍ΢ϐ Զᡏಒझኧ

௃ݩΠǴӵ

ԃжߡςගр ȑǵխܭғ౛

m pain, inju Ϸ߄౜҅தՉ

ᅽճϐҞ኱

ᕭ෧Ӛ୯ܭ୏

ៈڐ཮ϐፓ ภ܈ԝΫ 7Вঅ҅୏ނ ǴځύಃΟ

ǴԖ٬Ҕϐ ࣁϐǶȩǴջ

ᄊǴฅԶѠ , WTOȑࡕ ୯ሞচݨሽ ҁ࡭ុଯᅍ फ़եӚБԋ Ϸᒙယݹ٠ ϐ໒ᎍԶග ኧΞࣁғ٢ ӵՖԖਏ෧

рߥምၭ൑

౛ό፾Ȑfre ury or diseas

ՉࣁኳԄϐ

኱Ǵኻ࿉ܭ

୏ނᅽճೕ

ፓࢗҭᡉҢ Ǵ΋૓҇౲

ނߥៈݤϣ Οകಃ 15 చ

ϐѸाਔǴ ջӧ෧Ͽ၂

᡼ܭ ࡕǴ٬

ሽ਱΢

ᅍǴ࣬

ԋҁ٠ ٠ӈ٢ ගଯғ ٢ीሽ ෧Ͽ٢

൑୏ނ edom seȑǵ ϐԾҗ 2008

ೕጄϐ ҢǴջ

౲ჹ၀ ϣ৒Ǵ చϣ৒

ᔈа ၂ᡍ୏

(11)

εӭኧ୏ނ plingȑБԄ ۈૈࣁϐǴჹ ٢ύ֖Ԗᡏಒ ғ٢଺ࣁ၂ᡍ ޑǴҭёफ़ ғ٢ܭࣴزύ

ᆕ΢܌ॊ

ᡍБݤϐࡌҥ ஒଞჹ٢܊ݹ pling metho ଫరЃౚלচ ࡌҥεೕኳፓ

ނ၂ᡍύϐ Ԅ܌ڗளǴჹ

ჹܭεೕኳ ಒझȐsoma ᡍύϐ DNA फ़ե௦ኬၸ ύϐߕуሽ Ǵ٢Ҕ୏ނ ҥஒԖշܭ ݹ௓ᆅǴа odsȑԏ໣ғ চ DRB3.2 ፓࢗᆶػᅿ

ϐ DNA ٰ ჹܭ୏ނᡏ ኳ၂ᡍϐ௢ቶ

atic cellȑǴ AٰྍǴό ၸำύӢᏹբ ሽॶǶ

ނޑ੯ੰ௓ᆅ ܭ෧Ͽ࣬ჹ࿶

಻ើФ଺ࣁ ғ٢଺ࣁኬ

୷ӢȐBoL ᅿࡹ฼ϐୖԵ

ٰྍࣣࣁՈ ᡏࣣ཮೷ԋᓸ

ቶ܈ёૈࣁ Ъཕ٢πբ ό໻ё෧Ͽ୏

բѨ྽Զ೷

ᆅࣁ٢཰ว

࿶ᔮཞѨᆶ ࣁ၂ᡍჹຝ ኬҁٰྍǴଞ

LA-DRB3.2 Եၗ਑Ƕ

న܈ಔᙃ฻

ᓸΚᆶ৮ឨ ࣁόӕำࡋ

բΞࣁ؂В

୏ނ܌ڙϐ

೷ԋ୏ނᡏ

ว৖ϐख़ा

ᆶ຾ՉӚ࿶

ຝǴճҔߚߟ ଞჹځ٢ໆ

2 geneȑ࣬

฻аߟΕԄ ឨǴЪᏹբΓ

ϐᅉᛖǶ٢ ϐٯՉ٣໨

ϐᆙॐԶၲډ ᆶ၂ᡍΓ঩

ፐᚒǴԶ࣬

ᔮ܄ރϐຑ ߟΕԄ௦ኬ ໆǵ٢ಔԋϩ

ᜢ܄຾Չϩ

Ԅ௦ኬȐinv Γ঩ҭሡௗ

٢Ҕ࿶ᔮ୏

໨ϐ΋Ǵӵ ډঋ៝୏ނ

঩ϐ॥ᓀǴ

࣬ᜢࣴزၗ

ຑ՗ǶӢԜ ݤȐnoninv ϩǵᡏಒझ ϩ݋Ǵаբ

vasive

ௗڙ૽

୏ނϐ ӵૈճ ނᅽճ ٠ග

ၗ਑ᆶ Ԝҁࣴ

vasive झኧᆶ բࣁ҂

(12)

٢ҔФϐᅿ ΓᜪЎܴύ ځдৎ੬ӵ፜

ФࠔᅿǴฅӢ ԺҔϐൂ΋

٢ҔФϐࠔ

߻ޣΞᆀࣁ ኻࢪ฻Ӧǹު

ࣚ΢தـϐ٢ ٢ҔอفФ

΋ȑ಻ើФ

಻ើФଆྍ

ऍ୯ܭΜΐ ΜΐШइ҃ය ځׯؼǴࢂಃ

ฦൕȐHolste ҁβᆀᒏϐ stein-Friesi ӄШࣚ 93ʘϐ

಻ើФȐკ ଯǶвФϐр 360 kgа΢

ᅿᜪ ύനԐϐФ

፜ଫǵξԲ Ӣᐒఓϯϐ

΋ࠔسǴ܈

ࠔᅿёཷϩ ࣁኻࢪФǴ

ުঢ়ФΞᆀ ٢Ҕࠔᅿ֡

Фǵངᅟহ

ȐHolsteinȑ

ྍܭ಻ើᆶ ΐШइ߃ය යԋҥ಻ើ

ಃ΋ঁᇡۓ einburgȑǴࡺ

ϐ Friesian an Associat ϐಃ΋εࠔ კ 1AȑϐЬ рғख़ऊӧ

΢Ȑ16 Կ 18

Фଫ٢Ҕ૶ᒵ ԲǴᆶᆟԲࣁ ϐදϷ٬ளא

܈ࣁ٢ǵԺঋ ϩࣁද೯ФȐ

аᓬؼϐғ ᆀࣁӑࡋФ

֡ࣁኻࢪФ হФᆶ׳ᖻФ

ȑ

ᆶቺ୯ч೽ϐ යεໆЇ຾ྍ

ើФ٢Фฦᒵ ۓځࣁൂ΋ࠔ

ࡺӜࣁ಻ථ Фڐ཮ӝ tion of Ame ࠔᅿǶȐֺǴ

Ьा੝ቻࣁ ӧ 40kg Ѱѓ

8Дសȑջё

ມˣЎ᝘ᔠ

ᒵऊۈܭ΋

ࣁఁǶ౜ж אҔФଫς ঋҔᅿȐֺ

ȐBos Tauru ғౢਏ౗๱

ǴЬाҔܭ Ǵၨࣁ๱Ӝ Ф฻Ƕ

ϐ٢Ҕࠔᅿ

ྍԾܭቺ୯ ᒵڐ཮Ǵа ࠔᅿϐ୯ৎ ථฦȐHolste

Զࣁ΋Ǵ erica) Ǵஒ಻

Ǵ2006ȑ ࣁܴᡉϐ໵қ ѓǴԶԋዕϐ ё໒ۈଛᅿ

ᔠ૸!

΋࿤ԃ߻ǴႯ жФଫྍԾ ςόӆൺـ

ֺǴ2006ȑǶ usȑᆶުঢ়Ф

๱ӜǴЬा

ܭξ୔฻Ծ Ӝϐࠔᅿࣁ

ᅿǴځݜ٢ ୯಻ථฦൕ аݜ٢ૈΚ ৎǶோऍ୯ einȑǶ1885

҅Ԅ׳Ӝ

಻ើФػԋ

қ޸܈आқ ϐϦФᡏख़ ᅿǴځԋዕ

Ⴏϯԃж߾ӧ ٢ǵԺᆶא Ǵࢂࡺ౜Ϟ

ФȐBos Ind ၓᎦ୔ୱࣁ

๏Ծىϐᝄ

಻ើФǵྷ

ૈΚᆶғౢ

ϐ಻ើФ٠ ϐᔠۓᆶฦ ϐ಻ើФჴ ԃǴᆶࣁ؃

ࣁ Holstein ԋࣁଯғౢਏ

޸ЛՅǴᡏ ख़ёၲ 1,100

ᡏख़ऊࣁ 6

ӧཥҡᏔਔ אҔঋٳϐ ϞϐФଫࣣ

dicusȑٿε

ࣁчऍࢪǵ ᝄदᕉნǶ

ྷγ໳Фǵ

ౢਏ౗ࣣ࣬

٠уаપϯ ฦᒵ٠ख़ϐ ჴྍԾܭቺ

؃҅ӜԶ٬

n-Friesian ਏ౗ЪႩᎦ

ᡏࠠᅺεЪ 0 kgа΢ǹ 680 kgǶך

ਔжǴ ϐђж

ࣣࣁ٢

εᜪǴ ٥ࢪ Ҟ߻

ীۇ

࣬྽ᓬ ϯǴಖ ϐኳԄ ቺ୯಻

٬Ҕ಻

ڐ཮

Ꭶᓐኧ

Ъݜ٢ ζФ ך୯಻

(13)

ФܭВᏵਔж Фаว৖٢

಻ើФϐѳ 5ȑǶ

Βȑྷγ໳Ф

ྷγ໳Фচ ය໒ۈᇡۓྷ

ࣁၭ҇җቺ

ၨఁȐ20 Կ

໳ФϐϦ҆ԋ 0 kgک 4.0%

ΟȑীۇФ

ীۇФྍԾ Μӭԃ໔௢ቶ ؼӳЪऐಉ१

ীۇФȐკ ѰѓǶऩаൂ

ғౢਏ౗׳ଯ 6ȑǶࣁගܹ

23 Вঅ҅

٢ФࠔᅿǶী

΢Ǵᆶ٢ೈқ ٢ФࠔᅿǶ

жջЇΕѠ ٢Ф٣཰Ǵ ѳ֡Вౢ٢

ФȐBrown চౢܭྷγ

ྷγ໳Фࣁ ቺ୯Ї຾٠ 24ঁДȑǴ ԋዕᡏख़ϩ

%Ȑკ 1Bȑ

ȐJerseyȑ Ծमউੇ৙

ቶԿӄम୯ १ǴࡺϩѲ კ 1Cȑឦλ

ൂՏᡏख़ϐౢ

ଯܭ಻ើФ

ܹ୯ϣ٢཰ᝡ Ȩᅿ੬࿥Ϸ

ীۇФޑФ қ፦౗೿ၨ

᡼Ӧ୔Ǵՠ ٠ܭ 1977 ٢ໆࣁ 20.5

Swissȑ γܿч೽ϐ٢ ࣁ΋ࠔᅿǴோ

٠ׯؼྷγФ

ࢂதـ٢ ϩձӧ 850 k

Ƕ

৙ϐীۇ৞

୯ฦᒵǴ౜ࣁ ѲࣗቶЪёஏ λࠠФᡏࠠ

ౢ٢ૈΚຑ ФǹோӧѠ᡼

ᝡݾΚ٠ቚ ϷᅿচᒡΕӕ

٢ᚑՅၨ໳

ၨ಻ើФࣁ

ՠᏯࡕ໻Ͽ 7 ᆶ 1978 ԃ

kg а΢Ǵ

٢ԺঋҔᅿ

ோ΋૓࣬ߞ ФԶٰǶЛ ҔФᅿύന kgᆶ 550 k

Ǵܭ 1850 ԃ ࣁШࣚಃΒ ஏ໣Ԅܫށ ǴځԋዕϦ ຑ՗Ǵൂ΋ݜ

᡼ςӢک಻

ቚуФ٢ӭϡ ӕཀЎҹቩ

໳Ǵѳ֡ԃ ଯǴࢂന፾

Ͽኧ੮Ӹǹޔ ԃ໒ۈ٢Ф Ǵѳ֡٢િ

ᅿǴឦอف ߞځნϣϐ ЛՅࣁԪፃ നఁޣȐBri gѰѓǴѳ

ԃжԋҥী

Βε٢Фࠔ ށǶ

ϦФϐᡏख़ऊ ݜ٢යёғౢ

಻ើФᚇҬ ϡϯϐճҔ ቩਡाᗺȩǴ

ౢ٢ໆࣁ 4

፾ӝᇙբଆ

ޔԿ 1960 ԃ Фฦᒵᆶ٢Ф

౗߾ऊࣁ

Фϐ΋Ƕऍ

ྷγ໳Фଆ ՅǴᡏࠠӢ iggs and Br ѳ֡ԃౢ٢ໆ

ীۇФڐ཮

ᅿǶჹ਻ং

ऊࣁ 650 kg

ౢᡏख़ 12 ७ Զคપᅿϐ Ǵၭہ཮ܭ

҅Ԅஒীۇ 4800 kgǴ٢

љǵѪݨǵ

ԃࡕۈख़ཥ Фဂׯؼी

3.62 % Ȑ

ऍ୯ܭΒΜ ଆྍܭྷγ ӢӦԶ౦Ъ riggs, 1980ȑ ໆک٢િ౗

Ǵ٠ܭௗΠ

ংکӦ౛ᕉ

gǴ҆Ф߾ࣁ ७а΢ϐ٢ ϐীۇФȐ ܭ҇୯ 95 ۇФӈࣁё ٢િ౗߾ӧ

ǵଳႀ฻٢ ཥЇΕ

ीฝǶ ȐഋǴ

ΜШइ γՋࠄ Ъ܄ԋ ȑǶྷ

౗߾ࣁ

Πٰޑ ᕉნ፾

ࣁ 450 ٢ໆǴ ȐֺǴ ԃ 6 ёᒡΕ 5.0%

٢ᇙࠔ

(14)

Ѥȑ٢Ҕอف ٢ҔอفФ ԋǴࣁ΋٢Ժ ቻࣁᡏอǵ଼

ΐШइ຾ՉՈ Фॿ኷೽

ety, http://w ᅿ٢Фڐ཮ϐ

Ǵ٢િ౗ᆶ

ϖȑངᅟহФ ངᅟহФܭ ninghamᆶ

܄ૈၨৡϐҁ ٠ׯؼǴۈ׎

ངᅟহФЛ

܄٫Ǵౢ٢ਏ ᆶଳႀǴࡺ྽

֡ౢ٢ໆ 600 ϷӄऍӚӦ

Ϥȑ׳ᖻФ

׳ᖻФচౢ

ᡏࠠύ฻٠ڀ

فФȐMilk ФऊܭΜΖ ԺঋҔࠔᅿ

଼֧ǴЪё Ո಍Ϸ܄ૈ

Ǵ٠ܭ 194 www.milkin

ϐ΋Ǵ౜Ϟ ᆶ٢ೈқ౗

ФȐAyrshir ܭ 300 ӭԃ ᆶ Ayrshire ฻ ҁβλࠠФ

׎ԋϞВϐ ЛՅࣁ໵Յ ਏ౗ϷࢲΚ

྽Ӧၭ҇ճ 00 kgǴѳ֡

ȐBriggs an

ȐGuernsey

ౢӦࣁݤ୯ ڀ఩ፃՅᆶ

king Shortho ΖШइύଆྍ

ǶϦФ܄ԋ ёғౢҜॠ

ૈฦᒵǴഌុ

48 ԃԋҥ٢ gshorthorn.

ϞӄऍӚӦ֡

౗ऊࣁ 3.0%

reȑ

ԃ߻ଆྍԾ

฻Οԛ׳Ӝ ФࠔᅿǴࡕ ϐངᅟহᅿ

Յ܈ᚇԖआፃ Κҭ࣬྽ᓬ ճҔࣗቶǶϦ

֡٢િ౗ࣁ nd Briggs, 19

ȑ

ч۞ϐ׳ᖻ ᆶқՅ࣬໔ϐ

ornȑ

ྍܭम਱ើ

ዕᡏख़ࣁ 9 Ȑკ 1DȑǶ

ុܭ 1882 ԃ ٢ҔอفФ .com/breed.

֡Ԗ٢Ҕอ

Ծ᝵਱ើϐང ǴനࡕݮҔ җ၀Ӧ୔ϐ Ȑკ 1EȑǶ

ፃՅϐಒ༾

ؼǴЪӢځ ϦФᆶζФ

3.9%Ƕऍ୯ 980ȑǶ

ᖻ৞Ǵऍ୯Ї ϐЛՅǴ҃

ើǴΏҗอ 900 kgа΢

Ƕऍ୯ܭΜ ԃԋҥऍ୯ Фڐ཮ȐAm

htmlȑǶ197 อفФϐႩᎦ

ངᅟহଗǴ Ҕ Ayrshire ϐၭ҇аम

༾ඬᗺǴᡏ ځФ٢ಔԋ Фϐԋዕᡏख़

୯ܭΜΐШ

Ї຾ࡕܭ 1

ัೀ஥Ԗқ

فФуம٢

΢Ǵ҆Ф߾ࣁ ΖШइ҃२ อفФڐ཮

merican Mi 72ԃ٢Ҕอ Ꭶǹѳ֡ԃ

ว৖ၸำ ϐࠔᅿӜԿ উੇ৙ϐځ

ࠠύ฻Ǵჹ ҽ፾ӝ຾΋

ख़ऊࣁ 850 Шइ߃යЇΕ

877ԃߡԋ қඬǴሷ೽߾

٢ໆϐᒧܘ ࣁ 650 kg а २ԛЇ຾Ǵ

཮Ǵ1912 ԃ ilking Shor อفФ҅Ԅ ԃౢ٢ໆࣁ

ύᐕ࿶ Du ԿϞǶԐය ځдФᅿу

ჹᕉნϷ਻

΋؁уπᇙ kgᆶ 550 Ε၀ࠔᅿǴ

ԋҥ׳ᖻФڐ

߾ࣁ٢໳Յ ܘ୻ػ а΢Ǵ ٠ܭ ԃԋҥ rthorn Ԅӈࣁ

9000

unlop, යࣁౢ

уаᚇ

਻ং፾

ᇙԋѪ kgǴ

౜ς

ڐ཮Ǵ ՅȐკ

(15)

Ƕᆶεᡏࠠ

٢િᆶଯ٢ೈ

Ԗၨอϐౢ

ҁǶԋዕϦФ

%Ƕோӧ೚ӭ ӧᎦᓐኧς೴

ࠠϐ٢Фࠔᅿ

ೈқ፦ϐФ

ౢв໔ຯᆶ Фख़ऊ 750

ӭ୯ৎࣣठ

೴ԃΠफ़Ƕ

ᅿКၨǴځ Ф٢ᆪӜǴૈ

ᆶၨԐϐ߃ౢ

kgǴ҆Ф߾

ठΚว৖ᡏࠠ

Ȑ஭ک໳Ǵ

ځൂՏ٢ໆჹ

ૈ፾ᔈྕ዗

ౢԃសǴࡺ

߾ࣁ 500 kg

ࠠၨεЪᕴ 2005ȑ

ჹႩ਑௦१

዗ϐᕉნ਻

ࡺԖճܭғ gǹѳ֡ౢ٢ ᕴౢ٢ໆଯ

१ໆϐКॶၨ

ংǵ໣ऊԄ

ౢਏ੻ϐග ٢ໆࣁ 5600

ϐ಻ើФ௃

ၨଯǴЪа Ԅܫށ฻Ⴉ ගϲᆶफ़ե 0 kgǴ٢િ

௃ݩΠǴ׳

ағౢ

ႩᎦБ եႩᎦ

િ౗ࣁ

׳༞Ф

(16)

! ! ! !

தـϐ٢ فФǹ ure 1 Comm

D. Mil

! ! ! ! !

ҔФଫࠔᅿ E.ངᅟহФ mon breeds i

lking Shorth

! !

ᅿǺA. ಻ើ

Фǹ F. ׳ᖻ in dairy cow horn, E. Ayr

B.

D.

F.

ើФǹ B. ྷ ᖻФȐ஭ک ws. A. Holst

rshire, and F

ྷγ໳Фǹ ک໳Ǵ2005ȑ

tein, B. Bro F. Guernsey

C. ীۇФ ȑǶ

wn Swiss, C yȐ஭ک໳

Фǹ D. ٢

C. Jersey, Ǵ2005ȑ.

٢Ҕอ

(17)

٢܊ݹϐϟ

΋ȑ٢܊ϐᄬ ٢Фϐ٢܊

Ԝϩ܊໔٢Ҋ

΋ᖓጢϩ႖ ٢Ҋᒡଌϐ ٢Ҋ߯ܭݜ alveoliȑǴӆ ԣϷ٢ᓐ๚ύ ٢Ҋਔ܌ሡϐ ٢܊ϐ߻ᆄ ٢ᓐྎௗӝೀ

ٛᑇѦٰ༾ғ ၰȐഋǴ199

Βȑ٢܊ݹϐ ٢܊ݹȐm

౛ബ໾ǵϯᏢ ٢ᓐ຾ΕФ ݜ٢ФǶФଫ ϸᔈȐinflam ᘋનȐinterfe ᔈ࡭ុ຾Չ

у ว ݹ ೽ Տ ocompatibili

ϟಏ ᄬ೷

܊߯җѤঁ

Ҋ٠ό࣬೯ Ƕ٢܊ϣ೽

ϐᆅၰϷ٢ ݜ٢ಒझӝ ӆ຾΋؁ಔ ύǶѰѓ٢ ϐᔼᎦȐഋ ᆄࣁ٢ᓐǴ

ೀԖኧቫᕵ ғނϐགࢉ

98ȑǶ

ϐཷॊ

mastitisȑࣁ ᏢᛰᏊ܈ಒ Фଫᡏϣࡕ ଫӧᎁڙੰ

mmationȑǴ eronȑ฻ಒ Ǵวݹ೽Տ Տ ϐ ٛ ᑇ բ

ity complex

ঁᐱҥϩ܊ಔ ೯ǶځύѰѓ

೽ಔᙃҗჴ ٢ԣ฻ឦϐ ӝԋǴҗ೚ӭ ಔԋ٢ဏယ

٢܊֡Ԗځᐱ ഋǴ1998ȑǶ

х֖٢ᓐ๚

ᕵӛϐᛐጢ

ࢉǶ٢ᓐྎ

ࣁ٢Фख़ा

ಒ๵གࢉԶౢ

ࡕǴܭ٢܊

ੰচ๵གࢉਔ

٬қՈౚኧ ಒझᐟનϐբ Տஒӧ 56 λ

բ Ҕ Ǵ ٠ xǴMHCȑ

ಔԋǴ؂΋

ѓϩ܊җύ

፦Ϸ໔፦܌

Ǵ໔፦ಔᙃ ӭݜ٢ಒझ ȐlobuleȑǶ٢

ᐱҥϐ୏ે

๚Ȑteat cist Ǵջࣁᖗᖚ җѳྖԼᠼ

தـ੯ੰǴ

ౢғวݹϸ ύଶ੮ᆶғ ਔǴߡ཮Ӣ ኧҞቚуǴ

բҔΠᏤठ λਔϣթᅈѮ

຾ ΋ ؁ ೸ ஒלচև᝘

΋ϩ܊ڀԖ ύᝌ໧஥܌

܌ᄬԋǴჴ ᙃ߾ࣁคݜ झӆᄬԋελ

٢ҊຟӸܭ

ેՈᆅٮᔈ

ternȑϷ٢ ᖚᛐȐfurste ᠼᆢ܌ᕉᙅ

Ǵځวғচ ϸᔈǴځύ ғߏǴ຾΋

Ӣᡏϣխࣝ

ӧϟқન- ठқՈౚ۳ ѮᏘಒझȐ

೸ ၸ Ь ा ಔ

᝘๏రЃౚ

΋ঁ٢ᓐᆶ

୔႖Զԋ

፦ಔᙃڀԖ ٢фૈϐ่

λऊ 50~25 ܭ٢झ๚Ȑl Ǵёόᘐග

ᓐྎȐteat nbergs rose Ǵࣁ٢ᓐ๚

ӢፄᚇǴ΋

Ξаಒ๵ག

؁೸ၸཕ٢ س಍ϐٛᑇ 8Ȑinterleu วݹ೽Տᆫ Ȑmacrophag ಔ ᙃ ࣬ ৒ ፄ ౚаЇวᆶ੝

ᆶ΋ᐱҥ٢ Ǵ߻ࡕϩ܊

Ԗϩݜфૈ

่ጌಔᙃϷ 50 mϐౚ lumenȑǵ٢ ගٮݜ٢ಒ

canalȑǶ٢ etteȑǴЬा

๚ᆶѦࣚϐ

΋૓߯ࡰ٢ གࢉࣁЬǶ ٢೛ഢ໺ࢉ

ᑇᐒᙯԶЇ ukin-8, IL-8 ᆫ໣Ƕ΋ѿ geȑ฻ൂਡ ፄ ӝ ᡏ Ȑ m

੝ۓלচ࣬

٢ဏǴ

܊߾໻

ૈǴ٢ Ϸિެ

ౚރ٢ ٢ᆅǵ ಒझӝ

٢ᓐ๚

ाфૈ

ϐ୤΋

٢ဏӢ

༾ғ

ࢉ๏ځ วݹ 8ȑϷ ѿݹ܄

ਡౚǴ major

࣬ᜢϐ

(18)

Ϻխࣝϸᔈ ҊϐᔼᎦǴӢ

ݹϐФଫғ қՈౚ຾Ε ӧѠ᡼٢ actiaeȑǵߎ ዀ๵ȐMycop 2ȑǶऩа٢

clinical mas Ᏽ߈ԃଞჹѠ

ੱȐketosisȑ ౦ՏȐdispla

౗നଯϐ੯ੰ

ค٢᜘ౚ๵

! ค٢᜘

Фްǵཕ٢ ϟǴ٠ܭᔒ ౚ๵ߡёِ

ޑ୴ᑈ཮у

೷ԋᝄख़ϐ 2003ȑ

ȐBenjamin ӢԜܭ٢܊

ғ٢ύࣣё Εғ٢ύ܌

Ф௼ဂύ ߎ໳ဟ๻ౚ๵

plasma spp

٢܊วݹำࡋ stitisȑᆶߚ Ѡ᡼ᛌᙴৣ

18.1%ǵബ acement of a

ੰȐഋ฻Ǵ

ȐStretococ

᜘ౚ๵ࣁ࣬

٢ᐒᏔ܈ᏹբ ᔒ٢ਔ໺ࢉԿ

ِೲጭۯག уமݹ܄ϸᔈ ϐ੯ੰǴՠ٢

ni et al., 200

܊วݹਔՈన ёෳளၨଯϐ

܌ठǶ Ǵ٢܊ݹϐ

๵ȐStaphyl .ȑکεဉఎ ࡋᆶ٢ύᡏ ߚᖏ׉ࠠ٢܊

ৣᖏ׉ບᘐइ ബ໾܄ီண

abomasum, 2008ȑǶ૟

ccus agalac

྽தـϐ٢ բΓ঩೏ག Կ҂གࢉϐ

ࢉԿ᏾ঁФ ᔈǴ຾Զઇ ٢܊ϐ่੷

03ȑǶҗܭ٢ నύϐൂਡ ϐᡏಒझኧ

ϐЬाठੰ

lococcus au

ఎ๵ȐEsch ᡏಒझኧࣁ٩

܊ݹȐsubcl इᒵࡰрǴ गݹȐtrau

DAȑ15.9%

૟ϟಏЬाੰ

ctiaeȑǺ

٢܊ݹठੰ

གࢉ٢୔ϐ٢ ϐ٢୔ǶӢԜ ФဂǴՠεӭ ઇᚯౢ٢ಔᙃ ёૈቹៜԛ

٢ဏڀԖؼ ਡౚߡ཮ε ኧȐsomatic

༾ғނࣁค ureusȑ฻ٿ hericia Coli

٩ᏵǴۘё linical mast

٢܊ݹϐว umatic reticu

%฻วғ౗

ੰচ๵ӵΠ

চǴЬाӸ ٢ҊԦࢉࡕ Ԝӧཕ٢ፁ ӭឦܭߚᖏ ᙃǵफ़եౢ

ԛ΋ݜ٢ය

ؼӳϐՈనٮ ໆ෢Ε٢ဏ cell counts,

ค٢᜘ౚ๵

ٿᅿॠើМ໚

iȑ฻ځдੰ

ёӆ຾΋؁ϩ itisȑٿεᜪ วғ౗ऊࣁ

ulitis, TRȑ

౗ٰளଯǴࠅ ΠǺ

Ӹӧς೏གࢉ

ࡕǴߡ཮ԋࣁ ፁғόؼϐ௃

ᖏ׉܄ੱރ

ౢ٢ໆ܈ಖԿ ϐ߄౜ǶȐH

ٮᔈаගٮ ဏύǴᏤठ , SCCȑǴ߯

๵ȐStretoc

໚܄๵Ǵа

ੰচ๵Ȑߋ ϩԋᖏ׉ࠠ

ᜪȐഋǴ199 ࣁ 8.7%Ǵᗨ 21.7%аϷ ࠅࣁ٢Фౢ

ࢉޑ٢୔Ǵ ࣁ໺ኞੰ๵

௃ݩΠǴค Ƕಒ๵жᖴ Կค٢Ƕᗨ Hogan and S

ٮӝԋ ठགࢉ

߯Ӣ٢

occus

аϷФ ߋ฻Ǵ

ࠠ٢܊

98ȑǶ ᗨ҂ၨ

ϷಃѤ

ౢࡕి

΋ѿ

๵ޑ൞ ค٢᜘

ᖴቲނ ᗨၨϿ Smith,

(19)

ߎ໳ဟ๻ౚ

! ߎ໳Յ բ཰঩฻җ

෗ࡕ຾Ε٢ س಍ઇᚯǴ

૓Զقߎ໳

फ़ե 15%ϐ

߾ஒ೷ԋค

ᡖዀ๵ȐMy

! ᡖዀ๵

ଫǹऩ੬ဂ ςᎁڙགࢉ

ᕍਏ݀ό٫

εǴࡺஒ೷

εဉఎ๵Ȑ

! εဉఎ

਑ǴЬाྍ

ޑѤ७Ǵӧ Їଆϐੱރ ฯ⫒ǵ዗ག ԝΫǶӢε ຬၸ΋ঁД Smith, 2003

ౚ๵ȐStaphy Յဟ๻ౚ๵

җᔒ٢ၸำ ٢ဏಔᙃǴՠ

຾΋؁׎ԋ

໳ဟ๻ౚ๵ၨ

ϐ٢ౢໆǶ คݤൺচϐ

Mycoplasma

๵ၨ߻ॊٿᅿ ဂܭอਔ໔ϣ

ࢉǶڙགࢉϐ

٫Ƕҗܭᡖዀ

೷ԋ၀٢ϩ

Eschericia

ఎ๵ဂࣁॠ

ྍԾ୏ނ௨ݧ ӧଳ٢ය߻ٿ

ރࣁФଫϱ ག฻Ǵऩ҂Ϸ εဉఎ๵Їଆ

ДǴோ܌೷

3ȑǶ

ylococcus a

தᕷ෗٠ғ ύ໺ࢉ๏҂

ՠӧ҆Фي ԋᖋݰ٠ౢ

ၨ᜘ౚ๵ϐ གࢉ߃ය ಔᙃཞ্Ȑ

spp.ȑ

ᅿ༾ғނϿ ϣමᛈวڥ ϐ҆Фౢ٢ ዀ๵཮٬ག

܊ϐ҉Φཞ

ColiȑǺ

ើМ഍܄๵

ݧނǶ΋૓

ٿຼᆶϩ৆

ࡕ१ኅቲ๊

Ϸਔݯᕍ߾

ଆϐੱރܴ

ԋϐᖏ׉܄

aureusȑǺ

ғߏܭФଫ

҂ڙགࢉϐ يᡏځд೽Տ

ౢғ่੷Ǵջ ϐ໾্׳ࣁ

ۘё೸ၸݯ ȐHogan and

ϿـǴோځ໺

ڥ֎س಍੯ੰ

٢ໆ཮ܴᡉΠ གࢉ٢܊ᠼᆢ

ཞѨǶ

๵ǴӸӧܭ٢

૓ԶقǴଳ٢

৆߻ٿຼϐག

๊ǵว዗ǵ

߾ஒ೷ԋ؁Չ

ܴᡉЪёԐය

܄٢܊ݹ՞

ϐ٢ᓐྎ

٢୔Ǵܰӧ ՏҭёӸࢲ ջߡࢂࡼѺ ᝄख़Ǵࣴز ݯᕍԶࡠൺ d Smith, 20

໺ࢉ܄ཱུଯ

ੰ܈ᜢ࿯ဍ Πफ़Ǵགࢉ

ᆢϯǴ೷ԋ

٢Фްᕉნ ٢ය໔ޑε གࢉКٯࣣ

Јၢኧቚу Չ֚ᜤǴԿ

යݯᕍǴࡺ

ᕴགࢉੰٯ

Ȑteat canal ӧ٢ᓐҜጥ໾

ࢲǶགࢉࡕ཮

Ѻלғનҭᜤ زᡉҢѳ֡؂

Ǵฅ΋ѿᘉ 03, 2003ȑǶ

ଯǴёགࢉҺ ဍεਔǴߡሡ

ࢉ߃යߡ཮Ї ԋ٢܊ᖋဍ܈

ნύϐᕨߡ܈

εဉ๵གࢉК

ࣣ཮ܴᡉϲଯ уǵΠฟߡ ԿФଫςคݤ

ࡺӭࣁอයག ٯϐ 30%а

lȑǴ೸ၸᐒ

໾αϷ٢ᓐ

཮Ꮴठ٢܊

ᜤаਥନǴ

؂ᓐགࢉФ ᘉණԿ᏾ঁ

Ƕ

ҺՖԃសቫ ሡ਱Ѧݙཀ ЇวНဍЪ

܈٢ဏరЃ

܈ӚԄӦ݈

Кٯऊࣁݜ ଯǶεဉఎ ߡ ǵ٢܊ဍ ݤઠҥਔஒ གࢉǴε೽

а΢ȐHogan ᐒఓ܈

ᓐᆅቚ

܊Ꮴᆅ

ࡺ΋

Фଫஒ

ঁ٢܊

ቫϐФ ཀࢂց Ъځݯ Ѓ่ဍ

݈฻პ ݜ٢ය ఎ๵܌

ဍ๞ǵ ஒᏤठ

೽ϩό n and

(20)

Οȑᖏ׉܄٢

೸ၸԺ౳ᢀ ՅԖܴᡉׯᡂ ༧ǵՈన฻Ꮙ Ԝ໘ࢤ཮ౢғ

Ѥȑߚᖏ׉܄

ߚᖏ׉܄٢ ኧٰղۓǴځ ӧӢηǴ٠೷

Ъᜤаບᘐ ݹ܌೷ԋϐ

܌ҢȐRob

٢܊ݹȐcli ᢀჸ܈ᙖҗ ᡂǵဍ๞Ǵ ᏉڰނԶ೷

ғੵภϷό

܄٢܊ݹȐ ٢܊ݹᗨค ځགࢉ౗ࣁ

೷ԋ٢ౢໆ ᘐǴӧ࿶ᔮ ϐཞѨଯၲ

bert et al., 2

inical masti җ౦தϐ٢Ҋ

׭܈᝻ᄗਔ

೷ԋФ٢ಔԋ ό፾གǶ

subclinical คݤаԺ౳ޔ ࣁᖏ׉܄٢܊

ໆᆶғ٢ࠔ ᔮ΢ࣁ࣬྽ำ

ၲ 180 ऍϡ 2005ȑǶ

itisȑǺ Ҋཱུܰղۓ ਔёག᝺ಔ ԋҽϐׯᡂ

l mastitisȑǺ ޔௗղۓǴ

܊ݹޑ 15

፦ϐΠफ़Ƕ ำࡋϐཞѨ ϡа΢Ǵ؂ԃ

ۓᖏ׉܄٢ ಔᙃр౜ฯ ᡂǴࣣࣁᖏ

Ǵՠёа೸

Կ 40 ७Ǵ Ƕߚᖏ׉܄

ѨǶਥᏵ಍

ԃӢ٢܊ݹ

܊ݹϐԖค ϯ೽ՏǴа

׉܄٢܊ݹ

ၸϩᚆੰচ ࣁᙯᡂԋᖏ ٢܊ݹߏය

ीǴऍ୯ѳ ݹЍр߾ຬၸ

คǶऩ٢܊

аϷ٢Ҋύ ݹϐੱރǶ

চ๵܈ीᆉ ᖏ׉܄٢܊

යӸӧܭݜ ѳ֡؂ᓐ٢ ၸٿሹऍϡ

܊Ѧᢀ ύ֖Ԗ Фଫ

ᆉᡏಒ

܊ݹϐ ݜ٢ಔ ٢ФӢ ϡǴӵ

(21)

ऍ୯՗ी

le 1 Evaluat

Ca Yields r

Milk Earlier Fewer de Pharma Veteri Manp

To

ी؂ԃ؂ᓐ tions of the

auses reduction

discard renewal epreciation aceuticals

inarians power

otal

Ӣ٢܊ݹϐ every-year

ϐཞѨ loss caused

Loss ($

116.10 24.44 13.60 9.94 9.68 4.84 2.42

181.02

炷modif

d by mastitis

$) 0 4 0

2

fied from Ro

s per cow in

% 64 14 8 5 5 3 1

100

obert et al., n USA

4 4

0

, 2005炸

(22)

ϖȑ٢܊ݹϐ Ѧᢀᔠࢗ

! хࡴ٢ Ѧᢀǵჹᆀ

ࢂցၸଯǵ Ԗฯ༧ǵဍ ᚑՅϷ֡፦

Ԑว౜ᆶݯ

CMTᔠᡍݤ

! ԜݤҔ Ԁ٢܊ݹ၂ ᙃಥပϐ΢

Չಔᙃϐঅ ٢ဏಔᙃύ ٢ύᡏಒझ ٠όڀෳۓ ჴҔϐຑ՗

ᏤႝࡋȐele

! Ꮴႝࡋ 1cm2ᘐय़ ॶ཮ୃৡऊ

ྕࡋୃৡǴ ʚ ਔځᏤ

ϐதҔᔠෳ

٢Фيᡏ଼ந ᆀ܄ᆶελࢂ

Ԗคੵภϸ ဍ๞ǵᡂ׎܈

፦ࡋ฻ࢂց҅

ݯᕍǴࡺၨ

ݤȐCaliforn Ҕٰຑ՗٢ ၂ᡍȐCalifo

΢ҜಒझϷ অံǴ΋ѿ٢ ύǴ೷ԋᡏ झኧऩຬၸ؂

ۓᡏಒझኧ

՗ࡰ኱Ƕ

ectrical con ࡋ(Electrical Ǵߏࡋ 1cm ऊ 1.9%ǴӢ ٠а 25ʚ

ႝࡋϟܭ

ෳБݤ

ந௃׎ϐᢀ

ࢂցԖѦ໾

ϸᔈǴаϷ

܈่੷฻ܴ

҅தǶՠऩ

৒ܰ೏۹ౣ

nia mastitis ύᡏಒझኧ fornia Masti

ՈనύқՈ ٢ဏಔᙃӢ

ಒझኧ࡚ᗊ

؂డϲ 50 ϐሺᏔ೛ഢ

nductivity, E Conductivi m ϐనࢊਔ ӢԜᏤႝࡋϐ ʚਔϐਠ҅ॶ 4.0~5.5mS/

ᢀჸᆶ٢܊

໾܈౦த౜ຝ Ϸ٢܊ಔᙃ

ܴᡉੱރ฻

ऩࣁߚᖏ׉܄

ౣǶȐಷǴ2

s test, CMT ኧޑӭჲǴࣁ

itis Test, CM ՈౚǴܭ҅த Ӣബ໾܈ᎁڙ

ᗊቚуȐ߄

࿤ঁǴջё ഢǴࡺᔠᡍ

ECȑϐෳۓ ity, EC)ࣁన ਔႝߔϐॹኧ ϐໆෳ೯த ॶ߄ҢϐȐ /cm ϐ໔Ǵ

ຎບϷ᝻ບ ຝǴ٠ᔈҔ ǵ٢ဏኲᆶ Ƕཕ٢߻ϐ

܄٢܊ݹǴ 005ȑ

ȑ

ࣁ౜൑നத MTȑǶғ٢ தݜ٢ය໔ ڙੰচ๵ག

2ȑȐPhilpo ёᇡۓ၀Ф

БԄᙁߡϐ

ۓ

నᡏႝߔॶ ኧǶ྽ྕࡋ தܭ 25ʚਔ ȐNielen et a

ǴФ٢ύቹ

ບ฻Ƕ٢܊ᔠ Ћ᝻ບག᝺

ᆶ٢ᓐࢂց҅

ϐ߻٢ᔠࢗҭ

߾ၨόܰ೸

த٬Ҕϐᔠᡍ ٢ύᡏಒझΏ

΢Ҝಒझ཮

གࢉǴՈύқ ot and Nick Фଫςᎁڙག

ϐ CMT ߡԋ

ॶϐॹኧǴۓ ࡋׯᡂឪМ ਔۓྕෳۓ al., 1992ȑǶ

ៜᏤႝࡋॶ

ᔠࢗᔈᕉ៝

᝺٢܊Ҝጥ

҅தǴ٢܊

ҭёаΑှ

೸ၸѦᢀᔠ

ᡍБݤǴᆀ ΏྍԾܭ٢

཮Ծฅಥပ қՈౚߡ཮

kerson, 198 གࢉǹՠӢ ԋࣁ΋ᅿ໔

ۓကࣁႝࢬ 1ɗਔǴᏤ Ǵց߾ሡा

Ƕ҅தФ٢ ॶελനЬ

៝٢܊

ጥྕࡋ

܊ࢂց

ှ٢Ҋ ᔠࢗϷ

ᆀࣁу ٢ဏಔ ပϷ຾

཮෢Ε 85ȑǶ Ӣ౜൑

໔ௗЪ

ࢬ೯ၸ Ꮴႝࡋ

ाਠ҅

ӧ 25 Ьाࣁ

(23)

Na+, K+ک C ᆶᡶᜪӅӕ

ႇᚆη෧Ͽ ٢ဏ๚ύǴ

཮ᏤठФ٢ et al., 1992

Զ೷ԋФ٢

஻Ԗ٢܊ݹ

٢ύ༾ғނ

྽Фଫр

࡭ុΟϺࣁ

߾ё຾Չ༾

ᕴ٢Ȑbulk

Cl-Οᅿᚆη ӕፓ࿯ϐǴฅ ϿǴ೷ԋ٢ဏ ᔆံᅖ೸ᓸ ٢ύ٢ᑗک

ȑǶ྽Фଫག ٢ϐᏤႝࡋ ݹǴࡺёᙖ

ނϐ୻Ꭶ р౜ᖏ׉܄٢

ࣁ΋୷ᘵᕍำ

༾ғނ୻Ꭶ

milkȑύᡏ

ηϐᐚࡋǶ ฅԶ྽٢܊

ဏ΢Ҝಒझ ᓸϐόىǴठ

K+ ޑᐚࡋ གࢉ٢܊ݹ

΢ϲǹ྽ځ җෳۓᏤႝ

٢܊ݹਔǴ ำǹऩ٢܊

аղᘐࢂց

ᡏಒझኧᆶ

҅தݜ٢ਔ

܊ݹวғਔ झᅖ೸բҔϗ

ठ٬Ф٢Ꮴ ࡋफ़եǴԶ ݹਔǴ٢ύϐ ځᏤႝࡋຬၸ

ႝॶ຾Չղ

཮Ӄࡼаቶ ݹੱރ٠҂

ցሡ௦ڗځ

ᆶғ๵ኧϐᔠ

ਔǴ٢ဏ๚

Ǵ٢ဏ΢Ҝ ϗ຾ǴՈన Ꮴႝࡋวғᡂ

Na+ ک Cl ϐ໊ᚆηᆶ

ၸߐᘖॶ 5 ۓ٢܊ݹϐ

ቶਏ܄ᛰᏊ

҂ܭ΋ԿΒ дଞჹ܄Б

ᔠࢗǶ

๚ϣᅖ೸ᓸϐ Ҝಒझڙཞ నύϐ໊ᚆη

ᡂϯǴҭջ٢

- ᚆηޑᐚ

ᆶෛᚆηᐚࡋ 5.6 mS/cmਔ ϐԖคǶ

Ꮚϒаݯᕍ ΒঁᕍำࡕԖ

БԄуаݯ

ϐѳᑽӄᒘ Ǵ٬٢ᑗϩ ηᆶෛᚆη ٢܊ݹวғ ᐚࡋቚуȐN ࡋஒ཮΢ϲ ਔǴջёղ

ǴаԐఁӚ Ԗܴᡉϐׯ

ᕍǶ

ᒘ٢ᑗ ϩݜϷ ηᅖΕ ғਔǴ Nielen ϲǴӢ ղۓځ

Ӛ΋ԛ ׯ๓Ǵ

(24)

Ф٢ᡏಒ le 2 Relation

Somatic cell

ಒझኧ֖ໆᆶ nships betw

l countsȐ×

14 ~ 19.5 22.5 ~ 38 42 ~ 120 128 ~ 228

ᆶ٢ౢໆཞ ween somati

104 /mLȑ

ཞѨԭϩК c cell count

炷modified f ᜢ߯

ts and loss i

Milk yi

from Philpo

in milk yield

elds lossȐ%

5 8 9 ~ 18 19 ~ 25

ot and Nicke ds

erson, 1985炸

(25)

Ϥȑ٢܊ݹϐ ٢܊ݹவག ԜǴऩ׆ఈૈ

ϐᆅ౛૽ግǵ ёԖਏफ़եੰ

ཕ٢ᕉნϐ

! ନཕ٢ ࢱҭ࣬྽ख़ ᗉխੰচ๵

ҭ࣬྽ख़ा

ᏹբΓ঩ϐ

! ନᔈௗ

ғ૽ግ฻࣬

ϐФଫ٢܊

٢܊ϐమዅ

! ཕ٢߻

੮ܭ೛ഢύ ӆаરτᔔ ࡕϐ႖ᚆ܄

ଳ٢යϐೱ ϐᕍำࣁ٫

ၲډԖਏϐ

ϐݯᕍᆶ௓

གࢉ҆Фஒ

ૈԖਏ௓ڋ ǵଳృϐ٢܊

ੰচ༾ғނ

ϐమዅᆶ೛ഢ ٢ਔϐᐒఓᓸ ख़ाǶФဂύ

೸ၸᐒᏔ໺

ाǶ

ϐ૽ግ

ௗڙֹ๓ϐཕ

࣬ᜢᖱಞǴִ

܊ബ໾Ǵۘё

ዅᆶ੆ᅄ

߻ሡᄇۭమዅ ύǹ٢ᓐܭႣ ᔔଳ٢ᓐࡕ঺

܄ᛰ੎੆ᅄё ೱុ܄٢ᓐ႖

٫ǶฅӢӚቷ ϐᛰ੎ਏ݀

௓ڋ

ஒੰচ๵໺ኞ ڋ໺ࢉ܄٢܊

܊Ϸ٢ᓐ٠ ނޑණኞǶ

ഢᆢៈ

ᓸΚሡᛙۓ ύऩςԖᖏ׉

໺ࢉԿ଼ந

ཕ٢௲ػ૽

ִ๓؂ঁཕ ёٛЗठੰ

ዅФଫϐ٢ Ⴃࢱᔒక߻٢

঺΢٢݆Ǵ ёԖਏफ़ե ႖ᚆ੆ᅄё ቷจϐᛰ੎

ȐHogan an

ኞԿ҂གࢉ

܊ݹǴཕ٢ ٠ܭཕ٢ࡕ

ۓаᗉխ೷ԋ

׉܄٢܊ݹ நϐФଫǶԜ

૽ግǴჹ೛ഢ ཕ٢ᕉ࿯Ǵନ

ੰচ೸ၸᏹբ

٢܊ᆶ٢ᓐ฻

٢όҔǴ٠ ё෧Ͽ੮ӧ եӢᕉნύε ёԖਏ௓ڋᕉ

੎٬Ҕࣣόᅰ nd Smith, 20

ࢉФଫǴځ໺

٢ᕉნϐమ

຾Չ੆ᅄǴ

ԋނ౛܄ബ ݹϐФଫǴᔈ ԜѦǴߥ࡭

ഢᏹբԖ΋

ନёᗉխ೷

բΓ঩ܭФ

฻೽ՏǴᗉ ٠ᛰ੎٢ᓐ٬

ӧ٢ᓐ߄Ҝ εဉ๵܌೷

ᕉნЇଆϐ ᅰ࣬ӕǴᒥ 003ȑǶ

໺ࢉ൞ϟЬा

ዅᆶ೛ഢϐ аϷႩ਑ᔼ

ബ໾ϐѦǴཕ ᔈஒځཕ٢ԛ

࡭Ф൑ଳᔿమ

΋ۓዕ஼ࡋѦ

೷ԋӢᐒఓᏹ ФဂύҬΰག

ᗉխӢᕨߡ฻

٬ځᆶ੃ࢥ Ҝޑ༾ғނ

೷ԋϐ٢܊

ϐ٢܊ݹགࢉ

ᒥൻ٬Ҕᇥܴ

ाࣁཕ٢೛

ϐᆢៈǵᏹ ᔼᎦᆶࣝभ

ཕ٢߻ࡕ҅

ԛׇፓԿന మዅ٠ۓය

ѦǴۘሡௗ

ᏹբόؼ܌

གࢉϐёૈ

฻ᕉნύᠢ ࢥНௗ᝻ 30

ǶԜѦǴܭ ݹགࢉཥੰ

ࢉǴа 2 Կ

ܴ҅ዴᏹբ

೛ഢǶ ᏹբΓ भ฻Ǵ

҅ዴమ നࡕǴ ය੃ࢥ

ௗڙፁ

܌Їଆ

ૈǶ

ᠢԦᅉ

ࣾǴ ܭཕ٢

ੰٯǶ Կ 5 В բۈૈ

(26)

ࣝभᆶႩ਑

! ߈ԃٰ

෧Ͽ٢ᡏಒ ᡉҢǴݜ٢ ఎ๵ϐགࢉ

ܭଳ٢ය໔

๵གࢉ܌Ї ғન A ǵᆢ

೷ԋᕉნ܄

Չి؎ȐHo

਑ᔼᎦϩ

ٰ࣬྽ଯКٯ ಒझኧ٠ගଯ ٢Фံкೈữ

ࢉำࡋǴЪё ໔ࡼѺ̆-5 ε ଆϐᖏ׉܄

ᆢғન Eǵ

܄٢܊ݹϐว ogan and Sm

ٯϐчऍ٢ ଯౢ٢ໆǶ ữለɡᎋё ё٬҆Фܭ εဉఎ๵ࣝ

܄٢܊ݹੰ

ǵ-चᡀጱ วғ౗ቚу

mith, 2003ȑ

٢ФࣣᗯႩೈ

ճҔεဉఎ ёׯ๓٢ᆅف

ܭװࢥ၂ᡍ

ࣝभϐ҆ФႣ

ੰٯϐኧໆᆶ નǴаϷ༾

уǶऩФଫр ȑǶ

ೈữለɡᎋ ఎ๵װࢥᆶ ف፦નϐ׎

ύԖၨ٫ϐ Ⴃٛݙ৔Ǵ ᆶำࡋǹ࣬

༾ໆϡન⃯

р౜࡭ុϐ

ᎋǴёफ़ե٢ ᆶज़ڋᎋឪڗ

׎ԋǴ٠ё௨ ϐࡠൺำࡋ

ёԖਏफ़ե

࣬ჹԶقǴႩ ǵልکᎋ฻

ϐᄌ܄٢܊ݹ

٢ϣགࢉว ڗໆϐ၂ᡍ ௨ନ٢ᆅϣ ࡋȐಷǴ201 եݜ٢Ԑය Ⴉᙂύऩલ

฻᝜ނ፦Ǵ ݹǴ߾၀Ե

วғ౗ǵ ᡍ่݀

ϣεဉ 11ȑǶ යεဉ લЮᆢ

ࣣ཮

Եቾ຾

(27)

ғ٢ኬࠔճ

΋ȑғ٢٢ໆ ٢ໆ

٢ໆࣁ ϐݜ٢Ԕጕ ݜ٢Ф຾Չ

٢ᑗ

! ٢ᑗऊ ϐᇙԋΏ೸

Ȑlactose in

٢િ

! Ѡ᡼಻

ࣁಉᠼᆢ௦

િ౗Ǵ⟻ᜪ

િ౗Πफ़

٢ೈқ౗ᆶ

! ! ٢ೈқ ճҔႩᙂύ

౜҅࣬ᜢϐ ٢፦ᔠᡍф 11 mg/dlȑ

፦౗ࣁ 3.2

ճҔϐϟಏ ໆᆶಔԋϩ

ࣁၭ൑ύ؂В ጕǶ೸ၸ٢ Չౢໆଯե

ऊ՞٢ಔԋϩ

೸ၸ٢ለ๵

ntoleranceȑ

಻ើФϐ٢િ

௦१ໆϐᅱ ᜪᆒ਑߾Ӣ Ƕ

ᆶֿનේ

қᆶේϐϩ ύϐಉೈқ ϐ࣬ϕѳᑽ фૈǴԾ 20 ǵ҅தȐ11 2ʘѰѓǴֿ

ϩϐϟಏ

Вനࣁ၁ၩ

٢ໆϐ၁ჴ૶

եϩဂ׫аό

ϩϐ 4.67%

ஒ٢ύϐ٢ ȑதـܭ໳

િ౗ѳ֡ऊ ᅱ௓Ƕቚуң

ၨܰౢғЧ

ϩ݋Ьाᆶݜ

຾΋؁ϩှ

ᑽރᄊǹՉࡹ

002ԃ 12 Д ɴ17 mg/dl

ֿનේ֖ໆ

ၩϐኧᏵǴ೸

૶ᒵёԖਏ όӕሡ؃ϐ

%Ǵځख़ा܄

٢ᑗᙯඤԋ

໳ᅿΓᆶߚဴ

ऊࣁ 3.7ʘǴ ңҁࣽᆶ૔

Чለ฻િެ

ݜ٢Фૈໆ

ှӝԋ༾ғ

ࡹଣၭ཰ہ঩

Д໒ۈගٮ lȑϷၸଯ ໆ߾ऊࣁ 15

೸ၸჹ٢ໆ ਏి؎ౢໆե ϐВᙂǴаၲ

܄ᗨόϷ٢ ԋ٢ለаफ़ե

ဴ໵ΓǴࡺ

ႀၭЊё٩

૔਑ёගଯච

ެለࡺܰᏤठ

ໆϷೈқ፦௦ ғނϐೈқ፦

঩཮੬ౢ၂ Ф٢ֿનේ

Ȑɧ17 mg/

mg/dLȐ׵

ໆϐϩ݋ёᛤ եΠϐ٢Ф

ၲ׳Ԗਏ౗

ೈқᆶ٢િ

ե pH ॶǴЪ

ࡺϝࣁෳۓϐ

٩Ф٢ύϐ චว܄Όለ ठዦगวሇ

௦१ໆ࣬ᜢ

፦ਔǴ਽ޑ ၂ᡍ܌ཥԮϩ

ේϐኧᏵǴё dlȑǶ΋૓Զ

׵Ǵ2003ȑǶ

ᛤᇙൂ΋ݜ ФǴ٠ёჹ౜

౗ϐᆅ౛Ƕ

િ౗Ǵ୤ᓬ Ъ٢ᑗόऐ ϐࡰ኱ϐ΋

ϐ٢િ౗ϩ݋

ለԶճܭගଯ ሇ౦தǴ೷ԋ

ᜢǶ೸ၸ༾ғ ޑճҔᆶ዗ૈ

ϩ܌ࣁуம ёϩԋၸե ԶقǴФ٢ Ƕ

ݜ٢Ф

౜Ԗ

ᓬႀ٢ ऐڙੱ

΋Ƕ

݋բ ଯ٢ ԋ٢

ғނ!

ૈև ம DHI

եȐɦ ٢ೈқ

(28)

٢ᕴڰ׎ނ

! ! ѱय़΢

፦аϷᆢғ ύᕴڰ׎ނ ჹගଯᕴڰ ၸեਔǴё ݹ฻੯ੰа

ғ٢ᡏಒझ

! ! DHI ᔠ

֖ໆҭࣁၭ

ޕൂ΋ݜ٢ ݜ٢Фϐᡏ

ΒȑߚߟΕԄ ӧ௼ဂᒪ ҭ܈኱૶୏ނ

ғ ୏ ނ ϐ ࣴ oninvasive s

߈ԃٰǴ ӵᕨߡǵԳ DNA ٰྍǴ Ոన܈ಔᙃ฻

AȐmitocho ϐࣴزǴ୤ӧ

ނ

΢ϐ٢ቷӭ ғન฻Ԍନ ނǶᕴ٢ڰ ڰ׎ނǴ΋

ёቚуңҁ аٛݜ٢ໆ

झኧ

ᔠᡍൔ֋ύ

ၭ൑໔ϩભϐ ٢Фϐᡏಒझ ᡏಒझኧܭ؂

ԄڗኬБݤ

໺Ꮲϐࣴز ނǴԜᜪೀ

ࣴ ز ΢ ߡ ໒ sampling me

ςว৖р࣬

ԳЛǵᆒన ǴځҞޑࣣ

฻ߟΕԄڗ ondrial DNA ӧಒझਡϣ

Ԗϩ݋คિ

ନНϩᆶ٢િ

׎ނࣁଳނ

΋૓Զق٢ύ ҁࣽ૔਑аׯ ໆΠफ़Ƕ

ύϐᕴᡏಒझ ϐख़ा٩Ᏽ झኧǴԜ໨

؂డϲғ٢

ݤϐϟಏ ز΢Ǵ୏ނ

ೀ౛ၸำ֡཮

໒ ۈ Ⴔ ֌ ଆ ethodsȑ(W

࣬྽ӭϡϯ నǵЛᎳǴа

ࣁ׆ఈ೸ၸ ڗኬϐ DNA A, mtDNAȑ

୷Ӣಔ DN

િڰ׎ނϐ

િϐଳނǶ ނ፦௦१ໆ ύϐᕴڰ׎

ׯ๓ǹЪଳ

झኧࣁႀၭ

Ᏽϐ΋Ƕҗܭ

໨ϩ݋ኧᏵߡ ٢ύ֖ໆεܭ

ނ۳۳ሡा೏

཮ჹ୏ނᡏ ଆ ඹ ж ϐ ڗ Woodruff, 19 ϯϐߚߟΕԄ

аϷғ٢฻

ၸԜᜪኬҁ A ٰྍǶߚ ȑϐ PCR ቚ NAϐϩ݋΢

ϐၗ਑Ǵх֖

ค٢ڰ׎ނ ໆϐࡰ኱Ǵග

׎ނऊࣁ 12 ଳނ፦௦१ໆ

ၭന٫ᑔᒧϐ ܭᖏ׉٬Ҕ ߡᡉள਱Ѧ ܭ 50 ࿤ঁ

೏ਂਆ܈ᅉ ᡏҁي೷ԋ ڗ ኬ Б ݤ 993) Ƕ ԄڗኬБݤ

฻Ƕคፕࢂ

ҁаڗளؼӳ ߚߟΕԄኬ

ቚ൯аҔܭ

΢ϝԖ΋ۓ

֖٢ೈқ፦

ނᆶ٢િ౗

ගଯଳނ፦

ʘǶऩᕴڰ ໆόىਔǴ

ϐࡰ኱ǴԶ ϐ CMT ᔠ Ѧख़ाǶ΋૓

Ǵջ೏ӈࣁ

ᅉ੮ǵ኱૶฻

࣬྽εϐᆙ Ǵ ҭ ջ ߚ ߟ

ݤа଺ࣁ୏ނ

٬ҔՖᅿߚ ӳࠔ፦ϐ D ኬҁςԋфӦ ܭᅿձ᠘᛽ᆶ

ۓޑ֚ᜤࡋ

፦ǵ٢ᑗǵ᝜

౗ӝٳջࣁФ

፦௦१ໆջё ڰ׎ނᆶ٢

ҭሡݙཀᒙ

Զᕴ٢ᡏಒझ ᔠෳݤ٠ค

૓ԶقǴऩ ࣁ٢܊ݹФଫ

฻ǹԶคፕ ᆙॐǶӢԜ ߟ Ε Ԅ ڗ

ނᡏ DNA ߚߟΕԄኬ DNAǴ຾Զ ӦճҔܭಈ ᆶᅿ໔ᒃጔ Ǵӵᒃη᠘

᝜ނ Ф٢ ё࣬

િ౗

ᒙယ

झኧ ݤள ऩൂ΋

ଫǶ

ፕࢂਂ

ԜǴӧ ኬ ݤ

ϐٰ

ኬҁ଺

Զڗж ಈጕᡏ ጔӦ౛

᠘ۓǵ

(29)

ձ᠘ۓǴаϷ

Βȑағ٢଺

౜ϞςԖ

܈פ൨ёૈϐ ࣁ२ाፐᚒ ᙃࣁҞ߻നத

཮೷ԋ΋ۓ ҭࣣԖ॥ᓀǶ

΋໨ख़ाϐፐ ໆϐᡏಒझኧ

ٰྍڀԖჴҔ ܭғ٢ኬҁЬ ჹၨࣁֹ᏾Զ

ΟȑԾғ٢ኬ а໺಍ݤܜ

Ԗ᠙ܭ ރຑ՗ǴL ύܜڗ DN ᙦ൤Ǵՠ؂

ۑ࿯Ǵ܈ݜ

૽ግ܈ڐշ झ܈ёԋࣁ

Ϸঁᡏ᠘ۓ

଺ࣁߚߟΕ

೚ӭϩηᒪ ϐᒪ໺܄੯ Ƕᒿ๱ಔᙃ த٬Ҕϐ୷ ۓำࡋϐᆙ ǶӢԜǴӵՖ

ፐᚒǶ٢Ҕ ኧǴ܈ё଺

Ҕ܄ଯǵჹ Ьाڗளٰ

Զճܭεೕ

ኬҁܜڗ D ܜڗғ٢ኬ ܭаՈనύқ

Lipkin฻Γ NA ϐБݤ

؂డϲѳ֖֡

ݜ٢໘ࢤԶۓ շջё຾Չ ࣁ DNA ϐќ

ۓ฻ȐChu e

ΕԄڗኬϐٰ

ᒪ໺ࣴزמ ੯ੰǹԶӧፏ

ᙃٰྍόӕ

୷Ӣಔ DNA ᆙॐǴᏹբΓ

Ֆ೸ၸՈన Ҕ࿶ᔮ୏ނ؂

଺ࣁќ΋୷Ӣ

୏ނᡏᆙॐ

ٰྍࣁФଫ܈

ೕኳϐຑ՗К

DNAϐϟಏ ҁ DNA қՈౚ଺ࣁ

Ȑ1993ȑׯ ǴځࢬำҢ

֖ໆҭऊౣ

ۓǶФ٢ϐ Ǵ٬ځܭኬ ќ΋ߡճϐ

et al., 2006ȑ

ٰྍ

מೌᆶБݤճ ፏӭϩ݋מ

Ǵҭςว৖

AٰྍǹฅԶ Γ঩ҭሡ࿶

నᆶԼԺಔ

؂ВԐఁࣣ

Ӣಔ DNA ϐ ॐၨեǴаϷ

܈Բଫ฻٢ КၨȐPsifi

ࣁ DNA ٰྍ

ׯؼΑவᆒ Ңཀӵკ 2

ౣࣁ 104Կ 1 ϐ௦໣ࣁ؂

ኬҁڗள΢

ϐඹжٰྍ

ȑǶ

ճҔܭ୏ނ מೌ΢Ǵ׳ଯ

৖рόӕϐ ԶǴՈనϷ

࿶ၸ࣬྽ޑ ᙃаѦޑ೽

ࣣሡჴࡼཕ ϐඹжٰྍ

Ϸԋҁ࣬ჹ ٢Ҕ࿶ᔮ୏

idi et al., 20

ྍၨό፾Ҕ నܜڗ DN ǶФ٢ύ܌

107ঁǴຎځ ВٯՉπբ

׳ࣁቸ܄Ƕ Ƕ

ނᡏғౢ܄ૈ

ଯࠔ፦ᆶى ڗኬБԄ ϷԼԺಔᙃϐ

૽ግǴჹ୏

೽Տڗள୷ ٢բ཰ǴЪ

ྍǶағ٢଺

ჹၨࣁեሽ฻

ނǴࡺځғ 010ȑǶ

ܭ຾Չεೕ

NAϐБԄࡌ

܌֖ϐᡏಒझ ځ଼நރݩ բǴЪЙሡၸ

ӢԜǴФ٢

ૈϐ܄ރϩ ىໆϐ DNA

ǴԶՈనϷ ϐڗኬჹ୏

୏ނᡏ܈ᏹ

୷Ӣಔ DNA Ъғ٢ύ֖

଺ࣁߚߟΕ

฻ᓬᗺǶԜ ғౢ܄ރϐ

ೕኳ࿶ᔮ୏

ࡌҥ΋঺வ झኧᗨόϷ ǵ߃ౢ܈࿶

ၸӭϐᚐѦ ٢ύ܌֖ϐ

ϩ݋Ǵ

ٰྍ

ϷԼԺ

୏ނᡏ ᏹբΓ ߡࣁ

֖Ԗ΋

ΕԄኬ ԜѦǴ ϐ૶ᒵ

୏ނ܄

வФ٢ ϷԲ٢

࿶ౢǵ ѦΓ঩

ϐᡏಒ

(30)

а୘Ҕ঺ಔ

! ! җܭ୘

ۈ௦ҔӚԄ ಔᙃ฻໺಍

ϐ΋ǶPsifi ځύх֖ٿ

಍ϐٿᅿܜ Չຑ՗Ǵځ КǴReal-tim ᡉҢׯؼࡕ ࣁ٫Ƕҗܭ ኬϐؼӳٰ

ಔܜڗғ٢ኬ

୘Ҕ঺ಔܭ Ԅ୘Ҕ঺ಔ଺

಍ߟΕԄኬ di฻ΓȐ20 ٿಔ୘Ҕ঺

ܜڗݤ຾Չ ځ่݀ӵ߄

me PCRϩኧ ࡕϐ୘Ҕ঺

ܭԲ٢ύ܌֖

ٰྍǶ

ኬҁ DNA ϐ ܭ DNA ܜڗ

଺ࣁ DNA ҁ܌೛ीǴ 010ȑట჋၂

ಔǴаϷଞ КჹǴ٬Ҕ

3܌ҢǶ߄ ኧϐ Ct ॶ ಔᏹբำׇ

֖ϐ҅தᡏ

ϐёՉ܄

ڗਔගٮ࣬

ܜڗπڀ ӢԜӵՖᔈ ၂КၨϤᅿ ଞჹٿಔ୘Ҕ

ҔٰԾ 5 ঁ ߄ύКၨΑٿ

ǴаϷόӕ

ׇԖၨ໺಍

ᡏಒझኧࣁ

྽ϐߡճ܄

ǹฅԶǴ΋

ᔈҔܭߚߟ όӕБԄܜ Ҕ঺ಔϐᏹ

όӕ੬ဂϐ ٿঁόӕޑ

БԄ܌ሡϐ ݤ฻ँрϐ 106ঁа΢

܄ᆶז௘܄

΋૓୘Ҕ঺ಔ ߟΕԄኬҁߡ

ܜڗғ٢ύ ᏹբ؁ᡯ຾Չ

ϐ 15 ଫᆟԲ ޑ֎ӀॶКॶ ϐ DNA ܜڗ ϐ߄౜ǴЀа

΢Ǵςى୼଺

Ǵ೚ӭ၂ᡍ ಔӭ஑ࣁՈ ߡࣁځЬा

DNAϐᓬ ՉׯؼǴӆ Բ଺ࣁෳ၂ ॶǴႝݚϩ ڗਔ໔Ϸԋ аՈనҔϐ

଺ࣁߚߟΕ ᡍࣣ໒ Ոన܈

ाፐᚒ ᓬӍǴ ӆᆶ໺

၂а຾

ϩኧຑ ԋҁǴ ϐ঺ಔ ΕԄڗ

(31)

F m

уΕ prote

уΕ

კ 3!а໺಍

Figure 2 Flo methodsȐL

а؂ϩដ уΕᆶ

а؂ϩដ

౽ନ΢మ

уΕ 2 mL

einase K, dithio

4

уΕ฻ໆϐ

уΕᆶ

Ε 2N!bnnpojvn.

уΕ 600 L

уΕ 10

಍ݤܜڗФ ow charts o Lipkin et al.

ដ 1000 ×gǴ4ʚ ᆶғ٢฻ໆϐ 1/

ដ 1000 ×gǴ4ʚ

మనࡕуΕ 10

lysis bufferܭ

othreitolǴനಖ

42 ʚ᎜ᕏǴpw

ϐ phenol saturat

ᆶ qifopm ฻ໆ

.bdfubufǴ3 ७

L Buffer B5ȐN 11,000Øg ᚆЈ

00 L!Usjt.FE

٢ DNA ϐ of DNA extr

., 1993ȑ/

ʚᚆЈ 10 ϩដ /:&!ObDm ྋన

ʚᚆЈ 10 ϩដ

mLӣྋ pelle

50ʚу዗ 30 ϩ

ಖᐚࡋϩձࣁ 70

fsojhiu!

ted with Tris-ED

ໆϐ dimpspqip

७ᡏᑈϐપଚᆒ

NucleoSpin® Blo Ј 1 ϩដ!

EUB!cvggfs ӣ

ϐࢬำკȐL raction from

న!

ts!

ϩដ!

0 nMϷ 0.2 mg

DTA!

psn!

ᆒࡕܜ਻ᚆЈ!

oodȑǴ

ྋ!

Lipkin et al.

m milk by tra

g/mL!

., 1993ȑǶ!

aditional

(32)

Cost per sample (€)

Process duration Ct valuecElectrophoresis score 260/230 nmb 260/280 nma Extraction method 2.7 1.15 hours 1.15

24.3 (0.40) 23.7

45.0 (10.1) 1.67 (0.14) 1.73 (0.03)d Nucleospin¯ Blood Kit ¯ 2.9 2.9

1.15 hours 2.15 h

23.7 (0.41) 22.8 (046)

48.0 (9.6) 89.1 (10.0)

1.67 (0.14) 2.10 (0.14)

1.71 (0.03) 1.80 (0.03)

Nucleospin¯ Tissue Kit Modified Blood Kit 3.1

hours 2.15 hours

(0.46) 23.4 (0.41)

() 54.5 (10.1)

() 1.85 (0.14)

() 1.74 (0.04) Modified Tissue Kit 2.0 1.5 days

25.0 (0.39) 28.5 (10.52) 2.71 (0.14) 1.55 (0.03) Phenol-Chloroform 1.5 2.15 hours

24.1 (0.49) 11.5 (12.5) 1.43 (0.18) 1.43 (0.04) In-house protocol Rtifbbt260d280tlttitt (Modified from Psifidi et al., 2010) a: Ratio from absorbance at 260 and 280 nm to evaluate proteins contents. b: Ratio from absorbance at 260 and 230 nm to evaluate salts contents. c: From real-time PCR. dStddd: Standard error.

(33)

ФଫЬाಔ

΋ȑЬाಔᙃ Ьाಔᙃ࣬

Ьाಔ genesȑࣁ΋

ύǴځфૈ

ȐMHC cla

ࣴزύගр complex 2 ځύΓᜪ leukocyte a

୷ӢȐswin BoLA୷Ӣ

MHCܭ ԜҺٿঁᡏ Ѿϐ౜ຝǶ ϩηǴϿኧ Ϸᐋރँಒ ηǶόӕܭ ѾȐallelic

΋ঁᡏࣣё MHC୷Ӣ

ಔᙃ࣬৒ፄ

ᙃ࣬৒ፄӝ

࣬৒ፄӝᡏ୷ ಔᙃ࣬৒ፄӝ

΋ᅿৎ௼܄

ૈᆶխࣝس ass Iȑᆶಃ

рȐBenjam ȑȐკ 3Aȑ

MHC ୷Ӣ antigen, HL ne leukocyt Ȑbovine le ܭঁᡏϐ໔ ᡏ໔ϐ MHC ǶԜѦǴӧલ ኧӵ B రЃ ಒझȐdendr ܭځдխࣝౚ

exclusionȑ ёӕਔ߄౜

ȐBenjamin

ፄӝᡏ୷Ӣϐ

ӝᡏϐϟಏ

୷Ӣ

ӝᡏ୷ӢȐ

܄୷ӢȐMH

಍ϐלচև Βᜪ MHC mini et al.,

ǴϐࡕኧΜ ӢՏܭಃϤ LAȑȐკ 3B te antigen, eukocyte an ໔ڀԖ࣬྽ଯ

C߄౜ࣣό લЮᇨᏤӢ

ౚȐB cells ritic cellsȑ ౚೈқϷ T ȑϐ౜ຝǴ

౜ٰԾРБᆶ ni et al., 200

ϐࣴز

Ȑmajor hist HC genes fa և౜࣬ᜢǶ CȐMHC cla

2003ȑǴ೏

Μԃ໔ځӕ ϤဦࢉՅᡏ

Bȑǹӧ፜ଫ SLAȑǹӧ ntigen, BoL ଯࡋϐ୷Ӣ όᅰ࣬ӕǴࢂ

Ӣηϐ௃ݩ sȑǵૅဏ΢

฻߾ӕਔ٠ TరЃౚڙ

ԶࢂаӅᡉ ᆶ҆Бϐ M

03ȑǶ

ocompatibi amilyȑǴቶ

MHC Ьा

ass IIȑǶM

೏ᆀϐࣁ H-

ྍ୷Ӣҭഌ ᡏ΢Ǵᆀࣁ

ଫ߾Տܭಃ

ӧФଫύՏܭ LAȑǶ Ӣӭኬ܄Ȑg

ࢂࡺཱུܰ೷

ΠǴε೽ϩ

΢ҜಒझȐt ٠࡭ុ߄౜

ڙᡏǴMHC ᡉ܄Ȑcodo MHC ୷Ӣ

lity comple ݱӸӧܭૉ

ाϩԋٿᜪ HCനԐܭ 2୷ӢȐhi ഌុӧځд୏

ΓᜪқՈౚ ΎဦࢉՅᡏ ܭಃ 23 ဦࢉ

genetic poly

೷ԋಔᙃ౽෌

ϩಒझ໻߄ hymus epith

౜ಃ΋ᜪᆶ

୷Ӣ߄౜٠ ominantȑϐ Ǵคፕࢂಃ

ex genesǴM

ૉ෎୏ނ୷ Ǻಃ΋ᜪ M ܭ 1937 ԃӧ

istocompati

୏ނύ೏ว ౚלচȐh ᡏ΢Ǵᆀࣁ

ࢉՅᡏ΢Ǵ

ymorphismȑ

෌ਔౢғז

౜ಃ΋ᜪ M helial cellsȑ

ಃΒᜪ MH ٠คҬඹ୷ ϐБԄ߄౜

ಃ΋ᜪ܈ಃ

MHC

୷Ӣಔ MHC ӧλႵ ibility ว౜Ǵ uman SLA ᆀࣁ

ȑǴӢ זೲ௨ MHC ȑǵа HCϩ

୷Ӣ௨

౜ǴҺ

ಃΒᜪ

(34)



AA.

B.

კ 3! λ ȐBenjam Figure 3 geneȐB

λႵᆶΓᜪ M mini et al., 2

MHC gene enjamini et

MHC୷Ӣ 2003ȑǶ es of mice a

al., 2003ȑ

ǶA. λႵ

and human.

.

H-2୷Ӣ

A. mice H-

ǹB. Γᜪ H

2 gene; hum

HLA୷Ӣ

man HLA

(35)

ಃ΋ᜪ MH

ಃ΋ᜪ Ȑtransmem ձࣁ AǵB λౚೈқȐ ڀԖѤঁझ

! !

ಃΒᜪ MH

ಃΒᜪ Ϸ DRǹԜ ᆶ 39!lEb ϐ superfamily Ȑinvariant όᡂ୔ӧܭ চϩη่ӝ ȐTakeshim

MHCϐфૈ

΋ѿᎁ ࣁૈ୔ϩಒ

᝘фૈаֹ

presentation ٮᒣ᛽ϐ΋

྽לচ 9ঁữ୷ለ

HCϐϩη่

ᜪ MHC ୷Ӣ mbrane glyc

аϷ C ฻ Ȑ2 microgl

झѦ୔ୱϐ

HCϐϩη่

ᜪ MHC ୷Ӣ ԜΟঁझѦ୔

ϐऀጢᗐೈ

yȑԋ঩ϐ΋

regionȑᆶ ܭ่ӝ T ಒ ӝਔૈԖၨ

ma et al., 20

ᎁڙੰচ๵฻

ಒझࢂցς

ֹԋǶԜၸำ nȑǴࣁ MH

΋ೱՍϸᔈ চࣁϣғ܄

ለߏࡋϐอᴏ

่ᄬϟಏ ӢȐMHC c

coproteinȑǴ Οঁ୔ୱǹ lobulinȑа ϩηȐTake

่ᄬϟಏ ӢȐMHC cl

୔ୱࣣԖ 

ೈқǶಃΒᜪ

΋Ǵᆶಃ΋

ᆶᡂ౦ၨεϐ झϐ੝ۓ C εϐቸ܄Ǵ 08ȑǶ

฻לচགࢉ

ᎁڙགࢉǴ ำ౐ੋלচ HC ϩηܭ

Ƕ

Ǵջӧಒझ ᴏ两Ǵ٠೸ၸ

class Iȑӝ ǴڀԖΟঁझ ǹԜᜪೈқ аߚӅሽ่ӝ

eshima et a

lass IIȑԖΟ Ϸ  ٿᅿ୷ ᜪ MHC ࣁխ

΋ᜪ MHC ϐ ϐᡂ౦୔Ȑ CDϩηǴӵ

ࡺ T ಒझё

ࢉਔǴխࣝس аճ T ಒ চঅႬȐanti ܭಒझϣᆶל

झϣӝԋೈқ ၸ TAP-1 Ϸ

ԋ΋ϩηໆ झѦ୔ୱȐ

፦Ξ཮ᆶќ ӝБԄӸӧ

l., 2008ȑǶ

ΟᅿझѦ୔

୷ӢǴϩձ խࣝౚೈқ

ϐữ୷ለ่

Ȑvariable re ӵ CD8+ᆶ ёᆶ൳Я܌

س಍ջ཮໒ झ຾ՉբҔ igen process לচϐᴏ两

қ䁙ፄӝᡏ Ϸ TAP-2 ၮ

ໆऊ 43 kDa Ȑextracellul ќ΋ϩηໆ ӧܭಒझ߄य़

୔ୱǴϩձࣁ ёӝԋϩη ຬભৎ௼Ȑ

่ᄬࣣԖଯࡋ gionȑǶಃ΋

CD4+ǹᡂ౦

܌Ԗᜪࠠϐೈ

ۈ௴୏ٛፁ ҔǴሡᙖҗ

singȑᆶלচ 两่ӝ٠ၮଌ

ᡏǴ཮຾΋؁

ၮᒡೈқஒϐ

aϐऀጢᗐ lar domainȑ

ࣁ 12 kDa य़Ǵٿޣፄ

ࣁ DPǵDQ ηໆऊࣁ 4

immunoglo ࡋߥ੮ϐό

΋ᜪᆶಃΒ ౦୔߾٬ځ

ೈқ፦לচ

ፁᐒڋஒϐ MHCϐל চև᝘Ȑan ଌԿಒझጢ

؁फ़ှࣁऊ ϐଌԿϣ፦

ᗐೈқ ȑǴϩ ϐ 2 ፄӝԋ

Qǵа 6!lEb obulin όᡂ୔

Βᜪϐ ځᆶל চ่ӝ

ϐ੃ྐǶ לচև

ntigen ጢ΢а

ऊ 8 Կ

፦ᆛǶ

(36)

ӧϣ፦ᆛύ Կಒझ߄य़ Ոౚ฻Ѧٰ

ឪΕѮᏘಒ

ှࣁၨอϐ ԋፄӝᡏǴ al.Ǵ2003ȑ

MHCϩηӭ

ಃ΋ᜪ

፦ϩηҭ߄ ჹלόӕࠠ

ᜪϐ B ࠠط

ૉ෎ݹȐan ҥլМੰȐ ϐੰำว৖

ύǴᴏ两לচ य़ᆶ CD8+T

ٰלচਔǴ ಒझ฻Ǵ٠ᆶ ϐᴏ两᜘Ƕಃ

ӆ຾΋؁ஒ Ƕ

ӭኬ܄

ᜪᆶಃΒᜪ ߄౜рᜪ՟

ࠠᄊϐלচ طݹȐhepat

nkylosing sp ȐMarek’s di

৖ࣣᆶ MHC

চஒᒧ᏷܄

T ಒझڙᡏ ջ཮࿶झᏘ ᆶಒझϣϐ

ಃΒᜪ MH ஒϐև᝘Կ

MHC ୷Ӣ ϐଯࡋӭᄊ ǶԜѦǴM titis Bȑǵ่

pondylitisȑ iseaseȑǴک C୷ӢԖᜢ

܄ᆶಃ΋ᜪ ᡏ຾Չϸᔈ

ᏘȐphogocy ϐ៶ݰᑼӝԶ

HCӧᚆ໒ϣ ಒझ߄य़ᆶ

ϐᡂ౦୔ڀ ᄊ܄ǴԶԜᜪ MHC ୷Ӣ೏

่ਡੰȐtub ǵᆶང෷ੰ

ФଫқՈੰ

ᜢǶȐBenjam

MHC่ӝ ǶԶלচऩ ytosisȑ܈ϣ Զ຾΋؁ܭ ϣ፦ᆛࡕߡ ᆶ CD4+Tಒ

ڀ࣬྽ଯϐ ᜪᒪ໺ᡂ౦

೏ຎࣁᆶ੝

beroulosisȑ

ੰȐAIDSȑ

ੰੰࢥȐbov mini et al.Ǵ

ӝǴӆ೯ၸଯ ऩࣁ༾ғނ

ϣտբҔȐ ܭԜለ܄ᕉნ ߡ཮ᆶԜᜪอ

ಒझڙᡏբ

ϐӭᄊ܄Ǵ٬

౦೏ຎࣁ٬ঁ

੝ۓགࢉ܄੯ ǵᅫ੯Ȑma

฻ǹځдނ vine leukem

2003ȑ

ଯ୷Мᡏࡕ ǵೈқ፦ǵ endocytosis ნΠ೏ೈқ อᴏ两่ӝ ҔȐBenjam

٬ځ߄౜ϐ

ঁᡏૈ׳Ԗ ੯ੰ࣬ᜢǴ malariaȑǵሼ ނᅿӵᚊଫ mia virus, B

ࡕ೏ଌ

܈आ sȑ೏

қ䁙फ़ ӝ٠׎

mini et

ϐೈқ Ԗճܭ ӵΓ ሼޔ܄

ଫϐଭ LVȑ

(37)

ΒȑФଫЬा

ФଫరЃౚ ӧФଫ BoLAȑ୷

ಃ 23 ჹࢉ

೚ӭ࣬౦ϐ Ԝࢤׇӈܭ Ԝࢤख़௨ׇ

al., 2008ȑǶ ቹៜ CD4+ DOAǵDO

ԜѦǴΓ DQౢނǴ

ಃΒᜪ MH ӢТࢤࣣё

΋ঁ DRA

୷Ӣϩձ೏

ଯԶ೏ຎࣁ ԿϞςԖ೚

ߏࡋӭᄊ܄

қ፦฻ႝᗺ polymorphi oligonucleo electrophor ϩ ձ ࣁ ่ ӝ

ा࣬৒ፄӝ ౚלচ୷Ӣϐ ଫύǴMHC

ӢǴς೏ຎ Յᡏ΢Ƕᗨ ϐೀǶ२Ӄ ܭࢉՅᡏ΢೏

ׇӈܭФࣽ

ӧ IIa ୔ୱ ᇶշ T ಒझ BǵTAP1ǵ Γᜪϐ HLA

Զ BoLA ୷ HC୷Ӣύ ё߄౜ȐSch

୷ӢǴΟঁ

೏ᆀࣁ DRB ࣁၨख़ाϐ

೚ӭࣴزճ

܄Ȑrestrictio ᗺǵՈమᏢ

ism analysis otide analys esis, DGGE ӝ RFLP

ӝᡏ୷Ӣ ϐᙁϟ

୷Ӣ೏ᆀϐ ຎࣁФଫխ ᗨฅ BoLA ୷

ǴӧಃΒᜪ

೏ϩԋٿঁ

୏ނӵᆟԲ ୱύǴх֖ڀ

झϐज़ڋ؁

ǵTAP2ǵLA A୷Ӣܭಃ

୷Ӣ߾໻߄ Ǵຬၸъኧ hwab et al.

ঁ DRB ୷Ӣ B1ǵDRB2

୷ӢǴЀځ ҔόӕБԄ on fragment Ꮲࣴزǵൂި

s, SSCPȑǵ sis, SSOȑ EȑǴаϷᆫӝ

ϐ PCR-RF

ϐࣁФଫర

ࣝ܄ރᆶ੯

୷Ӣܭ่ᄬ ᜪ MHC ୷Ӣ

ঁၨλϐ୔

ԲᆶξԲϐ ڀԖЬाфૈ

؁ᡯǹIIb ୔ୱ AP2аϷ L

ಃΒᜪ MHC ߄౜΋ᅿ DR ኧϐ୷Ӣࠠڀ

, 2009ȑǶ΋

ӢǴ΋ঁ܈

Ǵᆶ DRB3 ځࢂ exon 2Ȑ

Ԅଞჹ BoL t length pol

ިᄬ׎ӭᄊ

੝Ԗׇӈჲ ǵᡂ܄ఊࡋ ӝ䁙ೱᙹϸ RFLP ݤ ᆶ

రЃౚלচ ੯ੰϐख़ा

ᄬ΢ᜪ՟ܭΓ Ӣ΢Ԗ΋ܴ

ୱǴϩձᆀ MHC୷Ӣ

ૈ߄౜ϐ୷ ୱ߾х֖ D LMP7฻୷ C୔ୱ཮ӕ R୷Ӣౢނ ڀԖ DQ ϐ

΋૓ԶقǴ

܈ٿঁ DQA 3୷ӢǴځ ȐDRB3.2 ୷

A-DRB3୷ lymorphism ᄊ܄ϩ݋Ȑ ჲਡ㧿ለࠠ

ࡋጤᡏႝݚ ϸᔈȐpolyme

่ ӝ ᡵ ୷

Ȑbovine le

ाᒪ໺ংᒧ኱

Γᜪϐ HLA

ܴᡉϐख़ཥ௨ ᆀࣁ IIa ୔ୱ Ӣҭς೏ว౜

୷ӢТࢤ DR DYAǵDYBǵ

୷ӢǶ

ӕਔ߄౜ٿᅿ ނᆶٿᅿа΢

ϐख़ᙟТࢤ Фଫ BoLA

ᆶ DQB ୷ ύ໻ DRB3

୷Ӣȑϐӭᄊ

୷Ӣ຾Չ௖૸

m, RFLPȑǵT single-stran ᄊϩ݋Ȑse ݚȐdenaturi

eras chain re ۓ ׇ ϩ ࠠ ݤ

eukocyte ant

኱૶ϐ΋Ǵ A୷ӢǴՠ ௨ӈ౜ຝǴ ୱᆶ IIb ୔

౜ȐTakeshi Rᆶ DQ ୷ ǵDMAǵDM

ᅿа΢ϐ D

΢ DQ ౢނ ǴЪԜख़ᙟ A୷ӢТࢤ

୷ӢǶΟঁ

3 ୷ӢӢӭ ᄊ܄׳ࣁᡉ

૸Ǵӵज़ڋ Tಒझࠠᄊ nd conform

equence-sp ing gradien reaction, PC ݤ ϐ PCR

tigen, Տܭ ՠϝԖ Ꮴठ

୔ୱǴ ma et

୷ӢǴ MBǵ

DRᆶ ނǶӧ ᙟϐ୷ ࢤх֖

DRB ӭᄊ܄

ᡉ๱Ƕ ڋТࢤ ᄊǵೈ

mation ecific nt gel CRȑǴ R-SBT

(38)

Ȑsequence ٠ࡌҥΑ೚

ຬၸ 110 ᅿ virus, BLV ȐJuliarena Zanotti et a

BoLA-DRB ࣁளډ PCRౢނ຾

ᏊϷሺᏔሽ ϕံϐТࢤ ำύௗ΢ d ЗܭҺ΋ਡ ᆄஒࣁ ddA ݚϩᚆόӕ ddNTPǴന ϐଯှ݋ࡋ ޑ୷Ӣࠠᄊ ҁࣴز

ྍǴӆ࿶җ

׆Ꮗૈࡌҥ

ࠠჹܭ٢ໆ

e-based typi

೚ӭ୷Ӣࠠ

ᅿ୷ӢࠠǴЪ Vȑǵ؅૫ੰ

a et al., 2008 al., 1996ȑǶ

3୷Ӣϐ P ډၨځдБݤ

຾ՉۓׇǴа ሽ਱ҭ࣬ჹ ࢤǴ٠ஒ dd

ddNTP ਔߡ ਡ㧿ለՏ࿼

ATPǵddTT ӕελϐ PC നࡕҗۓׇ೬ ࡋ੝܄Ǵࡺё ᄊǶ

زϐҞޑࣁ೸

җ PCR-SBT ҥၨࣁߡճ ໆᆶ٢ಔԋ

ingȑǶMilti Ǵу΢ၸѐ Ъ೽ϩ୷Ӣ ( dermato 8; Kulberg e

PCRۓׇϩ ݤଯϐှ݋

аճࡕុҔ

ܳ຦Ƕ२Ӄ dNTP షӝ ߡ཮٬ϕံ

ǴࡺճҔԜ TPǵddGTP

CR Тࢤࡕ ೬ᡏղ᠐ࡕ ё᠘ۓ੝ۓ

೸ၸߚߟΕ T ϐϩ݋ݤ ϐ௦ኬБԄ ϩϐቹៜǶ

iadou et al.

ѐځдࣴزϐ Ӣࠠς೏᛾

ophilosis )ᆶ et al., 2007

ϩࠠݤচ౛ϟ

݋ࡋǴPCR-S Ҕܭჹ୷Ӣࠠ

ӃǴճҔᆫӝ ӝܭ dNTP ύ

Тࢤคݤᝩ Ԝচ౛࿶ᆫ

ǴаϷ ddC ࡕǴ຾΋؁ճ

ࡕ᏾ӝрֹ᏾

ۓ୷Ӣ০΢฻

ΕԄ௦ኬϐБ ݤଞჹ BoLA

Ԅаճ҂ٰ

Ƕ

2003ճҔ ϐว౜ǴҞ

ܴᆶФқՈ ᆶᖏ׉܄٢

; Maillard e

ϟಏ SBTΏޔௗ

ࠠղۓा؃

ӝ䁙Ȑpolym ύǴ೸ၸЇ ᝩុፄᇙԶ ӝ䁙ᘉቚࡕ CTP฻ځύ ճҔሺᏔෳ

᏾ϐኳ݈ਡ

฻Տ୷Ӣϐ

БԄǴճҔ A-DRB3.2 εೕኳ၂ᡍ

ணԄᆫӝ䁙 Ҟ߻ςܭ DR

ՈੰੰࢥȐb ٢܊ݹϐל܄

et al., 1996;

ௗଞჹ BoLA

؃ࣗଯϐᒪ໺

meraseȑᘉቚ η຾Չᘉቚ

೷ԋಖЗǴ ࡕ܌ளϐ PC ύϐ΋Ƕ೸ၸ

ෳໆς຾Չό ਡ㧿ለׇӈ ϐӭᄊ܄Ǵ܈

Ҕ٢Фϐғ٢

୷Ӣϐӭᄊ ᡍϐ୷ᘵǴ٠

䁙ೱᙹϸᔈ RB3.2୷Ӣ bovine leuk

܄܈ܰག܄

; Xu et al.,

A-DRB3୷

໺ࣴزǴ୤

ቚрᆶኳ݈

ቚǹ΋ѿᘉ Ǵ٬ځ 3’ᆄ CR ТࢤǴ ၸଯှ݋ࡋ όӕᑻӀ኱

Ƕҗܭۓׇ

܈຾΋؁פ

٢଺ࣁ DN ᄊ܄຾Չ૸

٠௖૸όӕ ᔈϩ݋

Ӣว౜

kemia

܄࣬ᜢ 1993;

୷Ӣϐ

୤ځ၂ DNA ᘉቚၸ ᆄёಖ ځ 3’

ࡋϐႝ

኱ۓϐ

ׇϩ݋

פ൨ཥ

NA ٰ

૸ፕǴ ӕ୷Ӣ

數據

Table 4 Comparison of milk yield and milk components among sensitive, normal, and resistant groups  (%)  1215±042

參考文獻

相關文件

Objectives  To introduce the Learning Progression Framework LPF for English Language as a reference tool to identify students’ strengths and weaknesses, and give constructive

- Through exploring current events and social topics in project work and writing newspaper commentary at junior secondary level, students are provided with the

Help pupils create paradigmatic associations by introducing the superordinates of different sports (e.g. water sports, track and field events, ball games) and guiding them to

Making use of the Learning Progression Framework (LPF) for Reading in the design of post- reading activities to help students develop reading skills and strategies that support their

At the basic education level, students learn through three domains: visual arts appreciation and criticism, visual arts making and visual arts knowledge which are integrated

Hence, we have shown the S-duality at the Poisson level for a D3-brane in R-R and NS-NS backgrounds.... Hence, we have shown the S-duality at the Poisson level for a D3-brane in R-R

• We have found a plausible model in AdS/CFT that captures some essential features of the quantum hall eect as well as a possible experimental prediction. • Even if this is the

– The futures price at time 0 is (p. 275), the expected value of S at time ∆t in a risk-neutral economy is..